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Abstract

For post-stroke rehabilitation of the upper limbs, increased amounts of therapy are
directly related to improved rehabilitation outcomes. As such, a low cost therapy
platform is proposed suitable for facilitating active therapy and administering activeassist therapy to the shoulder/elbow region of the upper limbs of individuals post-stroke
in a local clinic or domestic setting. Enabling a person to undergo intensive
rehabilitation therapy outside of a rehabilitation hospital setting permits the amount of
therapy administered to be maximised. While studies have shown that technological
approaches to post-stroke rehabilitation do not produce better outcomes than equal
amounts of traditional therapy in a rehabilitation hospital setting, a technological
approach has the potential to have significant benefits when that therapy is being
undertaken in a local clinic or domestic setting, where the individual undergoing
therapy is relatively unsupervised. These benefits largely relate to a technological
approach being more motivational for the person than an equivalent manual approach.
However, for such an approach to be economically viable, effective, low cost devices
are required. This document presents and critically discusses the design of this proposed
low cost therapy platform along with possible routes for its further development.
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Chapter 1

Introduction

1.1. Project	
  Background	
  

According to the World Health Organisation (WHO), approximately 15 million people
suffer strokes worldwide each year [1]. Of these 15 million, about 5 million die. 66% of
these fatalities are in people over 70 years of age [2]. These figures are not evenly
distributed around the globe, with death from stroke being much less prevalent in the
developed world. In one study from the United States of America including only people
greater than 64 years old, it has been found that only 12.6% of people who suffered a
stroke died within 30 days [3]. In the developing world, the incidence of stroke is
increasing while in the developed world the incidence of stroke is falling due to efforts
to lower blood pressure and reduced smoking [1]. However, the effects of an ageing
population in the developed world offset this so that the overall rate of stroke there
remains high.
Based on statistics from Ireland, about 50% of stroke survivors make a full recovery and
a further 30% make an incomplete recovery, although they may not necessarily require
help with everyday activities [4]. The remaining 20% require help with at least one
activity of daily living. Some of the common difficulties encountered by stroke
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survivors include hemi-paresis (partial paralysis affecting only one side of the body)
(48%), an inability to walk (22%) and cognitive impairment (33%).
Many stroke survivors require nursing home placement after their stroke episode and
institutionalisation is considered to be one of the most adverse outcomes of stroke [5].
Based on statistics from Ireland and the United States of America, it is estimated that
17-20.4% of nursing home residents are there because of the effects of a stroke[6].It has
also been estimated that up to 80% of these stroke survivors in nursing homes have a
high level of dependency [6]. This represents a significant economic and social cost. To
quantify this, in the United States of America in 2010, the estimated direct and indirect
cost of strokes was $73.7 billion [3].Striving to improve the levels of post-stroke
rehabilitation can reduce these costs and allow more people to live more independent
lives.
The hemi-paresis that affects about 48% of stroke survivors frequently manifests itself
as limb impairment. An inability to adequately control one’s limbs results in an inability
to perform many of the activities of daily living. This in turn adversely affects a
person’s ability to live independently. Much research has been conducted into using
technology to aid in post-stroke upper limb rehabilitation therapy. For example, robots
have been used for post-stroke rehabilitation. Limb rehabilitation tends to be quite
repetitive with the person undergoing therapy repeating the same exercises many times.
Robots are excellent at performing repetitive activities and, as such, were first employed
in limb rehabilitation activities in the early 1990s[7].
Technological aids can be used for two purposes; to assist people in undertaking
exercises that they would otherwise be unable to complete and to provide a stimulating
medium through which rehabilitation therapy can be conducted. It also has the potential
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to take rehabilitation activities out of specialist rehabilitation centres and into local
clinics or even the domestic environment.

1.2. Project	
  Overview	
  

Rehabilitation technology for the upper limbs of persons post-stroke is the focus of this
project. As such, the following research question has been devised:
Is it possible to develop a low cost technological device for assisting in post-stroke
rehabilitation therapy for the upper limbs in a local clinic or domestic setting?
This research question was devised by the research team based on information presented
in the literature review (Chapter 2) and following consultations with the stroke
rehabilitation group in NUI Maynooth and with rehabilitation professionals from Enable
Ireland.
The aim of this project is to answer this research question through the development of a
prototype low cost therapy platform for therehabilitation of the upper limbs of
individuals post-stroke. The therapy platform is intended for both facilitating active
therapy and administering active-assist therapy to the shoulder/elbow region of the
upper limbs. The design and functionality of the device are then investigated with a
view to determining its potential suitability for use in a local clinic or domestic setting.
Detailed project objectives are presented in Section 1.2.1.
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1.2.1. Project	
  Objectives	
  
The project objectives are split into three high level objectives, each containing several
sub-objectives. The high level objectives are discussed in Chapters 2, 3 and 4
respectively.
•

Research all relevant aspects of stroke, post-stroke assessment, standard methods of
post-stroke rehabilitation and using robotics and other technology aids for post-stroke
rehabilitation.
To achieve this objective, a number of sub-objectives are required to be completed.
These are detailed below:
-

Researching the causes of stroke, its incidence and its common effects.

-

Researching mechanisms of post-stroke recovery.

-

Researching established methods for assessing individuals post-stroke.

-

Researching traditional, non-technical, post stroke rehabilitation therapy.

-

Researching technological approaches to post-stroke limb rehabilitation and the
different application and classes of such devices.

•

-

Researching in more depth the use of robotic devices for post-stroke rehabilitation.

-

Justifying the project aim based on the results of this research.

Determine the required functionality of the therapy platform and design the therapy
platforms mechanical, electronic and software systems.
To achieve this objective, a number of sub-objectives are required to be completed.
These are detailed below:
-

Defining therapy platform functional requirements so that it is suitable for use in a
local clinic or domestic setting.
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-

Developing the therapy platforms mechanical, electronic and software systems.

-

Estimating the system cost by individually examining the cost of it’s component
parts.

•

Evaluate the design of the therapy platform and its suitability as a rehabilitation tool
and for use in a local clinic or domestic setting.
To achieve this objective, a number of sub-objectives are required to be completed.
These are detailed below:
-

Discuss to what extent the therapy platform can be considered to be a low cost
device.

-

Discuss to what extent the therapy platform can be considered to be a suitable for
use in a local clinic or domestic setting.
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Chapter 2

Literature Review

2.1. What	
  is	
  a	
  Stroke?	
  

The brain, and every other organ in the body, depends on a constant supply of energy to
function normally. Fuel and oxygen for the brain are carried in the blood. The main
energy fuel used by the brain is sugar, carried in the serum of the blood. Oxygen is
carried in the haemoglobin of red blood cells. When a part of the brain does not receive
an adequate supply of blood, or when the blood doesn’t carry enough oxygen or sugar,
that portion of the brain becomes unable to perform its normal functions. “Stroke” is a
term used to describe brain injury caused by an abnormality of blood supply to a part of
the brain [8].
Stroke is a very broad term and includes a variety of different types of diseases
involving the blood vessels that supply the brain. Treatment depends on the type of
stroke and the location of the blood vessels involved [8]. Strokes can be divided into
two broad groups: haemorrhagic strokes and ischemic strokes. Haemorrhage refers to
bleeding inside the skull, either into the brain or into the fluid surrounding the brain.
The term ischemia refers to lack of blood. Haemorrhagic and Ischemic strokes are
opposites. Haemorrhage is characterised by too much blood inside the skull and
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ischemia is characterised by not enough blood reaching the brain. Ischemic stroke is the
more common type, accounting for about 80% of strokes [8]. In a study including only
people greater than 64 years old, it was found that 8.1% of people who suffered an
ischemic stroke died within a 30-day period. 44.6% of those who suffered a
haemorrhagic stroke died within the same period [3].

2.1.1. Haemorrhagic	
  Stroke	
  
There are several different sub-types of haemorrhagic stroke, named for the location
inside the skull where they occur. Haemorrhages within the brain substance are called
intra-cerebral haemorrhages whereas subarachnoid, subdural and epidural haemorrhages
all occur in the various membranes between the brain substance and the skull[8].
The rupture of small blood vessels within the brain substance leads to bleeding into the
brain. This is called intra-cerebral haemorrhage [8]. This bleeding tears and disconnects
vital nerve centres and pathways. It is most often caused by uncontrolled hypertension
(high blood pressure). The blood usually oozes into the brain under pressure and forms
a localised blood collection called a hematoma. Hematomas exert pressure on brain
regions adjacent to them and can injure these tissues. For example, if bleeding occurs
into the left cerebral (brain) hemisphere, the person often experiences weakness and loss
of feeling in the right limbs and a loss of normal speech, whereas bleeding into the
cerebellum will cause dizziness and a loss of balance. Large intra-cerebral
haemorrhages are often fatal as they increase pressure within the skull, squeezing vital
regions within the brain stem.
Subarachnoid haemorrhage is bleeding into the fluid that surrounds the brain[8]. It is
usually caused by the rupture of an aneurysm (a weakened artery with a wall that is
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ballooned outward). The aneurysm bursts, spilling blood into the fluid that circulates
around the brain and spinal column. This increases the pressure inside the skull and may
cause the sudden on-set of severe headache. The sudden increase in pressure causes a
lapse in brain function, sometimes causing the person to stare, drop to his knees or
become confused and unable to remember anything. Subdural and epidural
haemorrhages are most often caused by head injuries that tear blood vessels.

2.1.2. Ischemic	
  Stroke	
  
A decrease of blood supply to the brain is called ischemia. If the ischemia is prolonged,
it leads to the death of tissue, which is called infarction. There are three different
categories of brain ischemia; thrombosis, embolism and systematic hypo-perfusion[8].
Thrombosis is a local problem with a blood vessel that supplies the brain [8]. A disease,
such as atherosclerosis, may cause the blood flow channel in an artery to narrow. When
it is severely narrowed, blood flow is greatly reduced, causing some stagnation of the
blood. If this blood clots it can lead to a total blockage of the artery. An embolism is
when a particle breaks loose and blocks a distant artery[8]. An artery in the head or neck
can be blocked by a blood clot, or other particulate matter, that breaks loose from
another area of the body. Systematic hypo-perfusion is caused by low blood pressure
throughout the brain[8]. Abnormally slow or fast heart rhythms, cardiac arrest and
failure of the heart to pump blood adequately can all lead to diminished blood flow to
the brain. Another cause of diminished circulatory functions is the lowering of blood
pressure and blood flow resulting from an inadequate amount of blood and fluid in the
body. In individuals with thrombosis or embolism only one artery is usually blocked.
This leads to dysfunction in the part of the brain supplied by this blocked artery, which
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may show itself, for example, as a weakness of the limbs on one half of the body. In
contrast, hypo-perfusion leads to more diffuse abnormalities such as light-headedness,
dizziness, dimming of vision etc. These symptoms are caused by a general reduction in
blood flow and are not due to a loss of function in one local region of the brain.
Also, if the lack of blood flow is brief, or relatively minor, there may be temporary loss
of function during a brief period of ischemia, but function may then return to normal
when blood flow is restored. This temporary decrease in blood flow to a part of the
brain is often referred to as a transient ischemic attack[8]. These attacks may be caused
by the temporary blockage of an artery by an embolus that passes, or by temporary
inadequacy of the blood flow through a narrowed artery. These temporary attacks
indicate that something is wrong with the system and warn of the possibility of a stroke.
A stroke is distinguished from a transient ischemic attack by the fact that neurological
deficits in transient ischemic attacks clear spontaneously within 24 hours.

2.2. Assessment	
  and	
  Recovery	
  

2.2.1. Neuroplasticity	
  
Neuroplasticity, also called brain plasticity, is the ability of the brain to change, to make
new connections, in response to an individual’s experiences, external stimuli or damage
[9]. A key working hypothesis of rehabilitation science is that use-dependent plasticity
perseveres through motor system injuries and diseases [10]. There are practical
implications of this regenerative ability for people who have suffered impairment from

9

having a stroke. Areas of the brain that control motor function, speech etc. may be
damaged during a stroke but the brain has the ability to adapt to this so that these skills
are not gone forever but may be relearned over time.Neuroplasticity encompasses a
wide spectrum of phenomena that include alterations in cortical properties, such as the
strength of connections between synapses and the recruitment of novel brain regions
during task performance [11]. It is this potential for beneficial recovery that underlies
the motivation to develop more effective neurological rehabilitation methods.

2.2.2. Recovery	
  Stages	
  
The recovery period after a person has had a stroke is divided into three categories;
acute, sub-acute and chronic [12]. People are considered to be in the acute stage of poststroke recovery immediatelyafter suffering a stroke. During this time the focus is
generally on saving the life of the person and preventing damage from occurring.
People are considered to be in the sub-acute stage of post stroke recovery if they
havehad their stroke within the last six months. Finally, people are considered to
be in the chronic stage of post-stroke recovery if it is more than six months since they
had their stroke. These designations are widely used in the classification of individuals
participating in post-stroke clinical trials.

2.2.3. Neuroimaging	
  and	
  Electromyography	
  
Neuroimaging is the use of various techniques to image the function of the brain. These
techniques

include

functional

Magnetic

Resonance

Imaging

(fMRI),

Electroencephalography (EEG), Magnetoencephalography (MEG) and Diffusion Tensor
Imaging (DTI). Neuroimaging techniques have the potential to reveal patterns of neural
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activation after brain damage and perhaps more importantly to identify the rehabilitation
interventions that will best stimulate the restoration of brain activation patterns [11].
Neuroimaging makes it possible to study the function of the living human brain and
may play a critical role in guiding the development of evidence-based rehabilitation
interventions [11]. Additionally, neuroimaging data provides a means to quantify the
dynamic reorganization of patterns of brain activation associated with particular
rehabilitation approaches.A study that used fMRI was conducted by Luft et al. [13] in
2004. This study involved twenty-one people in the chronic state of post-stroke
recovery. It aimed to test ifthe cortical networks were re-organised in people who
showed improved arm function after rehabilitation therapy with a device called
BATRAC. BATRAC is a device for facilitating bi-lateral arm therapy whereby an
individual’s unimpaired arm is used to administer therapy to the impaired arm. At the
end of the trial the people who used BATRAC showed increased hemispheric activation
during paretic arm movement, measured using fMRI. Luft et al. stated that this provided
‘biological plausibility’ for the effectiveness of the BATRAC device to administer
effective post-stroke rehabilitation therapy.
Another important potential use for neuroimaging data is the prediction of recovery
after brain damage and efforts are on-going to determine whether this goal is achievable
[11]. For example, some researchers have tried to predict final recovery from stroke and
head injury based on initial patterns of brain activation. However, work to date has met
with limited success. This failure to predict final recovery from neurological injury or
damage stems from the intricacy of normal brain function, the complexity of brain
activation patterns and the simplistic research designs and predictive models that are
currently available [11].
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Electromyography (EMG) can also be used to assess individuals through measuring
their level of muscle activation. An example of this is given in a study by Lum et al.
[14] from 2004. In this study, Lum et al. used EMG to show improved muscle
activation patterns in people after a course of robot mediated rehabilitation therapy.

2.2.4. Impairment	
  Metrics	
  
Post-stroke impairment takes different forms depending on what areas of the brain are
affected. Therefore, it is important to comprehensively assess every individual poststroke, to measure any deficiencies that they may have.Thisenables the most effective
rehabilitation therapy to be provided. It is also important to be able to continually assess
persons throughout a course of rehabilitation therapy to measure their progress and thus
gauge the effectiveness of the therapy.
Human-administered clinical scales are the accepted standard for quantifying the motor
performance of people who have had a stroke [15] and are also used to assess people
undergoing robot-mediated therapy. There are a large number of these clinical scales in
existence for assessingmovement ability, spasticity, muscle power, ability to perform
the activities of daily living etc. However, there is a lack of consensus on exactly which
scales should be used in trials of rehabilitation robotic technology[12]and limited
literature describing how to select outcome measures based on the nature of the
intervention and the individual’s profile. As such, an analysis of the clinical assessment
scales used in trials of rehabilitation robot technology to date has been conducted and is
detailed in Table 2-1. The particular focus of the research outlined in this document is
on the rehabilitation of the upper limbs. As such, all of the trials detailed inTable 2-1
have focused on upper limb rehabilitation. The assessment scales mentioned in Table
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2-1 are the Fugl-Meyer Assessment (FMA), the Motor Status Score (MSS), the
Modified Ashworth Scale (MAS), the Medical Research Council Power Grading Scale
(MRC) and the Functional Independence Measure (FIM).

Recovery Study

Robotic

No. of

Stage

Device

Subjects FMA

MSS

MAS

MRC

FIM

Other*

NeReBot

35

YES

-

YES

YES

YES

TCT

Rabadi et al.

MIT

30

YES

YES

-

YES

YES

-

(2008) [17]

Manus

Sub-

Aisen et al.

MIT

20

YES

-

-

YES

YES

-

Acute

(1997) [18]

Manus

Sub-

Volpe et al.

MIT

56

YES

YES

-

YES

YES

-

Acute

(2000) [19]

Manus

Sub-

Hesse et al.

Bi Manu

44

YES

-

YES

YES

-

-

Acute

(2005) [20]

Track

Sub-

Lum et al.

MIME

23

YES

YES

-

YES

YES

-

Acute

(2006)[21]

Sub-

Rosati et al.

NeReBot

24

YES

YES

-

YES

YES

-

Acute

(2007) [22]

Sub-

Treger et al.

REO

10

YES

-

-

-

-

MFT

Acute

(2008)[23]

Therapy

Sub-

Hesse et al.

Bi Manu

54

YES

-

YES

YES

-

BBT

Acute

(2008) [24]

Track

Sub-

Zimmerli et al.

Pneu-REX 10

YES

-

YES

-

-

ACE-R,

Acute

(2012)[25]

Chronic

Whitall et al.

(Year)

Assessment Scales Used

Used
Acute

Masiero et al.
(2007) [16]

Acute

EHI
BATRAC 14

YES

(2000)[26]

-

-

-

-

WMFT,
UMAQS

13

Chronic

Burgar et al.

MIME

21

YES

-

-

-

-

-

MIME

27

YES

-

-

-

YES

BI

Fasoli et al.

MIT

20

YES

YES

YES

YES

-

-

(2003) [29]

Manus

Lum et al.

MIME

13

YES

-

-

-

-

EMG

BATRAC 21

YES

-

-

-

-

WMFT,

(2000) [27]
Chronic

Lum et al.
(2002)[28]

Chronic

Chronic

(2004)[14]
Chronic

Luft et al.
(2004)[13]

UMAQS
fMRI

Chronic

Daly et al.

In Motion 12

YES

-

-

-

-

AMAT

(2005) [30]

S-E

19

-

-

-

-

-

CMSA

47

YES

-

-

-

-

-

20

YES

-

YES

-

-

ROM,

(MIT
Manus)
Chronic

Chronic

Chronic

Kahn et al.

ARM

(2006)[31]

Guide

Krebs et al.

MIT

(2008) [32]

Manus

Coote et al.

Gentle/s

(2008)[33]

SCT,
NSA,
MotorAS

Chronic

Housman et al

T-WREX

28

YES

-

-

-

-

ROM

14

YES

-

YES

YES

YES

BBT,

(2009)[34]
Chronic

Bovolenta et al. ReoGo
(2009) [35]

FAT,
TUG,
EQ-5D

14

Chronic

Chronic

Posteraro et al.

MIT

(2009)[36]

Manus

Lo et al.

MIT

(2010)[37]

Manus

20

-

YES

YES

-

-

-

127

YES

-

-

-

-

WMFT,
SIS

Acute:

65

2/2

1/2

1/2

2/2

2/2

Sub-Acute:

241

8/8

3/8

3/8

6/8

4/8

Chronic:

403

12/14

2/14

4/14

2/14

2/14

Total:

709

22/24

6/24

8/24

10/24

8/24

* See list of abbreviations for the full name of the assessment metrics listed in the ‘Other’ column.
Table 2-1: Details of impairment metrics used in a selection of studies involving robotic rehabilitation
devices.

From Table 2-1it can be seen that by far the most commonly used assessment scale
across the many different studies is the motor domain of the FMA. The FMA measures
gross movement ability, in this case of the upper limbs. Due to its proliferation across
all studies, it will be necessary to use the FMA in any future studies. The next most
common measure is the MRC, which measures muscle power. The MRC is particularly
prominent in studies involving individuals in the sub-acute stage of recovery but was
only used in two of the fourteen studies involving individuals in the chronic stage of
recovery. It can be considered to be a requirement for all studies involving sub-acute
persons. The MSS and the FIM were also common, particularly in studies involving
individuals in the sub-acute stage of recovery. Finally, the MAS was used in about a
third of the studies. Further information on each of these assessment scales is given in
Table 2-2.
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Impairment

What is

Description

Index

Assessed?

Fugl-Meyer

Gross

A stroke specific, performance-based impairment index designed to

Assessment

Movement

assess motor functioning, balance, sensation and joint functioning in

(FMA)

Ability

hemiplegic individuals [38]. It is quantitative and lends itself to
statistical analysis for both research and clinical work [39]. It takes
30-35 minutes to administer the entire assessment (which is
considered to be quite long) but sections of it can be administered
separately.
Five domains of the Fugl-Meyer Assessment:
•

Motor functioning (upper and lower limbs)

•

Sensory functioning

•

Balance

•

Joint Range of motion

•

Joint pain

The motor functioning domain is most applicable to assessing the
results of robot therapy as it assesses movement, coordination and
reflex action of the shoulder, elbow, forearm, wrist, hand, hip, knee
and ankle. An overview of how to administer a Fugl-Meyer
assessment for the upper extremity in the motor domain is given in
Appendix D.

Motor Status

Fine

The Fugl-Meyer Assessment is not suitable for detecting fine or

Score (MSS)

Movement

complex movements or co-ordination. It only measures gross limb

Ability

movement. If a finer evaluation of isolated movements and the
complete range of motor function of the upper limb are desired then
the Motor Status Score should be used [40]. The motor status score
can be used to measure a subject’s shoulder, elbow, wrist, hand, and
finger movements.
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Modified

Muscle Tone

The Ashworth scale is a 5-point scale, with the subject scored from 0

Ashworth Scale

(Spasticity)

to 4 on each task that they undertake. Lower scores represent normal

(MAS)

muscle tone and higher scores represent spasticity or increased
resistance to movement. The Modified Ashworth Scale, proposed by
Bohannon and Smith [41] in 1987, added the grade "1+" and made
slight changes to the definitions of each score in order to increase the
sensitivity of the measure. The Modified Ashworth Scale is
considered by many to be the “gold standard” for measuring
spasticity [41] and is well suited to post-stroke individuals with upper
limb impairments [42]. It can be applied to muscles of both the upper
or lower body. The assessor extends the subject's limb from a
position of maximum flexion to maximum extension until the first
soft resistance is felt. Moving the subject's limb through its full range
of motion should be done within one second [41].
Modified Ashworth Scale - Score definitions:
0

No increase in muscle tone.

1

Slight increase in muscle tone. Minimal resistance at the
end of the range of motion.

1+

Slight increase in muscle tone. Minimal resistance
through less than half of the range of motion.

2

More marked increase in muscle tone through most of
the range of motion. Affected parts easily moved.

3

Considerable

increase

in

muscle

tone.

Passive

movement difficult.
4

Affected part rigid in flexion or extension.

Medical

Muscle

A measure for manually grading muscle power in a range from 0 to

Research

Power

5. It is widely accepted and frequently used [43]. When measuring

Council Power

muscle power with the scale, the assessor gets the subject to contract

Grading Scale

the muscle group being tested. The assessor may then apply a

(MRC)

resistance to try and overcome the muscle group.
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Score definitions:
0

No movement is observed.

1

Only a trace of movement is seen or felt in the muscle.

2

Muscle can move only if the resistance of gravity removed.

3

The joint can be moved against gravity only when all other
resistance is removed.

4

Muscle strength is reduced but muscle contraction can still
move the joint against external resistance from the assessor.

5

Muscle contracts normally against full resistance from the
assessor.

In a study conducted by Paternostro-Sluga et al. [43] to determine the
reliability and validity of the MRC scale it was found that it was a
measure with substantial inter-rater and intra-rater reliability,
demonstrated high validity and that it can be recommended for
clinical use. One caveat is thatneither the range of motion for which a
movement can be performed is considered nor is the strength of
resistance against which a movement can be performed defined.
Functional

Ability to

Developed to offer a uniform system of measurement for disability

Independence

perform

for use in the health system in the United States [44]. The level of a

Measure (FIM)

Activities of

person's disability indicates the burden of caring for them and items

Daily Living

are scored on the basis of how much assistance is required for the

(ADL)

individual to carry out activities of daily living. Six areas of function
are assessed (self-care, sphincter control, mobility, locomotion,
communication and social cognition), which fall under two
categories, Motor and Cognitive.

Motor Domain
Self-care:

Eating, grooming, bathing, dressing upper
body, dressing lower body, toileting.

Sphincter Control:
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Bladder management, bowel management

Transfers:

Bed, chair, wheelchair, toilet, bath, shower

Locomotion:

Walk, wheelchair, stairs

Cognitive Domain
Communication:

Comprehension, expression

Social cognition:

Social interaction, problem solving

Table 2-2: Description of relevant assessment scales.

2.2.5. Robot	
  Based	
  Assessment	
  
Using robots for administering post-stroke rehabilitation is discussed in detail in Section
2.5. However, it is appropriate here to discuss the use of robots to assess post-stroke
persons. As mentioned in section2.2.4, human-administered clinical scales are the
accepted standard for quantifying motor performance of stroke subjects. Although they
are widely accepted, these measurement tools are limited. They are time consuming to
apply and subject to problems with inter-rater and intra-rater reliability [15]. Inter-rater
reliability refers to the issue of different people assessing the same subject, but
obtaining different results. Intra-rater reliability refers to the issue of the same person
obtaining different results from doing the same assessment a number of different times.
In contrast, robot-based measures are highly repeatable, have the potential to detect
smaller changes than standard manual assessment measures and could potentially
reduce the time it takes to administer an assessment [15, 45]. Robot assessment
measures therefore have the potential to become very useful measures of post-stroke
recovery. However, while robot assessment measures have been devised for different
robotic therapy devices, the results obtained cannot be reliably compared with the
results obtained from other robotic therapy devices due to often significant variations in
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design. For robotic assessment techniques to become more prominent a detailed, cross
platform, widely agreed standard is required [45].
Although robotic and other objective metrics have proliferated in the literature, they are
not as well established as clinical scales and their relationship to clinical scales is
mostly unknown [15]. Some work has been done to attempt to remedy this. In a study to
estimate clinical scores (including FMA, MSS, MRC and MAS) from robot based
metrics, Bosecker et al. [15] found that the best results were achieved in estimating the
MSS from a set of eight kinematic metrics. They also particularly noted that the
performance of the model to determine the MAS Scale was particularly low. In another
study, Murphy et al. [46] measured various kinematic metrics for a group of healthy and
chronic stroke subjects as they reached for a glass of water, took a sip and then placed it
back on a table. They found that the number of movement units, the total movement
time and the peak angular velocity of the elbow discriminated best between the healthy
and the chronic stroke participants as well as between those in the chronic stroke group
with moderate and mild impairment. They suggest that these kinematic variables may
serve as an objective assessment of upper-extremity motor performance after stroke.

2.3. Post-‐Stroke	
  Rehabilitation	
  Therapy	
  

The overall aim of any post stroke rehabilitation program is to improve the affected
person’s ability to perform Activities of Daily Living (ADL). This goes beyond being
able to complete simple movements to being able to combine a large number of
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individual movements together to complete functional tasks in order to be able to live
independently. These tasks include things such as being able to dress or feed oneself
[47].Most traditional rehabilitation treatments for hemiplegic persons focus on passive,
non-specific movement approaches and compensatory strategies to promote
independence in the activities of daily life [48]. To achieve this, individuals are
typically taught to use their unaffected limbs and various assistive devices. However, a
number of more modern, proven approaches are now available and are recommended in
the Irish Heart Foundation national guidelines and recommendations on the care of
people with stroke [47] as currently the ideal form of rehabilitation for those who have
had a stroke. These include constraint induced movement therapy, bilateral arm training,
goal setting and mental practice. These are discussed in the following sections after a
brief description of range of motion exercises.

2.3.1. Range	
  of	
  Motion	
  Exercises	
  
Range-of-motion exercises are physical movements through the range of joint motion.
The elbow, for example, has a normal range of 145-155 degrees between extension and
flexion. There are three types of range of motion exercises; passive, active, and active
assist.
Passive range of motion is movement induced in a joint solely by another person or
persons or a passive motion machine[49]. When undergoing passive range of motion
exercise, the joint of the individual receiving the exercise iscompletely relaxed while the
outside force moves the body part, such asa leg or arm, throughout the available range.
For active range of motion exercises, movement of a joint is provided entirely by the
individual performing the exercise[49]. There is no outside force aiding in the
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movement. Finally, for active-assist exercises, the person undergoing therapy actively
tries to achieve a movement as the therapist manually assists in the movement[10].
Besides allowing persons to perform movements not possible without assistance, it is
thought that active assist therapy may generate new patterns of sensory input that may
influence brain plasticity.

2.3.2. Constraint	
  Induced	
  Movement	
  Therapy	
  
Constraint induced movement therapy is based on the principal of learned non-use[50].
Learned non-use develops during the early stages following a stroke as the person
begins to compensate for difficulty using the impaired limb by increasing their reliance
on their unimpaired limb. This compensation has been shown to hinder recovery of
function in the impaired limb [50]. Constraint induced therapy treatment seeks to
counter this and promote useful neuroplasticity by discouraging the use ofthe unaffected
limb and encouraging the use of the hemiplegic arm [48, 51]. This is often achieved by
retaining the unaffected arm in some form of sling. The person then uses their affected
arm intensively for a period. The sling helps the person to overcome their natural
inclination to use their good arm to complete tasks. It is essentially a form of active
therapy. Clinical trials have shown constraint induced movement therapy to be effective
in improving the level of movement in the affected upper limbs of subjects with both
sub-acute and chronic stroke [50, 52, 53].
Guidelines for post-stroke rehabilitation issued by the Irish Heart Foundation
[47]recommend the use of constraint induced movement therapy at least two weeks post
stroke. It has been suggested that starting constraint induced movement therapy much
earlier than this may result in increased brain lesion size and thus be harmful to
recovery [52].
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2.3.3. Bilateral	
  Arm	
  Training	
  
Bilateral arm training is a technique whereby an individual practices the same activity
with both arms simultaneously [54]. It is essentially an approach to active-assist therapy
and has emerged as an approach that leads to positive outcomes in addressing upper
extremity paresis after stroke [55]. Guidelines for post-stroke rehabilitation issued by
the Irish Heart Foundation [47] also recommend that bilateral arm training involving
functional tasks (such as picking something up) should be tried in any individual who
still has a limitation on arm function four weeks after having a stroke.

2.3.4. Mental	
  Practice	
  and	
  Setting	
  Goals	
  
Mental practice is a technique by which physical movements are mentally rehearsed in a
repetitive manner [56]. Mental practice increases motor skill learning and performance
in rehabilitative settings [56-59]as the same neural and muscular structures are activated
when movements are mentally practiced as during physical practice of the same skills
[56, 60-64].The Irish Heart Foundation national guidelines and recommendations on the
care of people with Stroke [47] state that mental practice of an activity should be taught
and encouraged in addition to conventional therapy to improve arm function. This is
supported by the results of a trial, reported by Page et al. [56], which suggest that a
traditional rehabilitation program that includes mental practice of therapy tasks results
in significantly increased outcomes.
The Irish Heart Foundation national guidelines and recommendations on the care of
people with Stroke [47] also strongly emphasise that every person who has had a stroke
and is undergoing rehabilitation should participate with medical professionals in setting
goals if at all possible. These goals should be set so that they are meaningful and
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appropriate to the person undergoing rehabilitation. Both short term and long term goals
should be set that are challenging but achievable. Involving the affected person in the
setting of goals ensures that these goals match the needs of that person throughout the
rehabilitation process. Every individual involved in the rehabilitation process should
have his or her wishes and expectations established and acknowledged.

2.4. Devices	
  that	
  Assist	
  in	
  Rehabilitation	
  

2.4.1. Spectrum	
  of	
  Complexity	
  
A spectrum of complexity for post-stroke rehabilitation therapy is shown in Figure 2-1.
This is based on a figure from Reinkensmeyer et al. [10] and is one means of
categorising rehabilitation therapy technology. Moving from left to right along this
spectrum increases the cost and the need for assistance for people using the particularly
technology. At the same time safety and the number of potential users both reduce.

Figure 2-1: The spectrum of complexity in rehabilitation therapy technology. Based on a figure taken
from Reinkensmeyer et al.[10].
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2.4.1.1. Rehabilitation	
  Objects	
  and	
  Passive	
  Devices	
  with	
  Sensors	
  
Rehabilitation objects are simple passive objects that assist in rehabilitation. An
example of a rehabilitation object would be the sling used to restrain a person’s arm
during constraint induced movement therapy, discussed in Section 2.3.2.
Passive devices with sensors can be motivational and can provide feedback to the user
on how well they have performed a task. However, if the user is unable to complete the
task correctly, a passive device is unable to provide any physical assistance. An
example of such a device is DroidGlove [65], developed by a group in the Università
degli Studi di Milano, Italy, and intended for wrist rehabilitation. DroidGlove is
essentially a software application that runs on a smart phone using the Android
operating system. A person performs exercises with their smart phone in hand while the
sensors that come built into the phone, such as an accelerometer and a digital compass,
record how well the person performed the exercise. Then, when the person next visits
their physiotherapist, the physiotherapist can easily determine how often and how
successfully they completed their exercises and then modify their therapy as
appropriate.

2.4.1.2. Simple	
  Robotic	
  Devices	
  for	
  Decentralised	
  Use	
  
An example of a simple robotic device for decentralised use is the Therajoy system,
developed by group at Marquette University, USA, which is used for upper-limb
rehabilitation therapy. Therajoy consistsof a Logitech force-feedback joystick that is
modified such that its shaft is roughly one metre long [66]. This allows a larger range of
movement to be accommodated. Springs are added to maintain the neutral position of
the joystick and, in one study, motors were used to provide assistive or resistive forces
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to the user. Therajoy is designed to be a low cost tool that will allow rehabilitation
therapy to continue in the home or with the assistance of a therapist in a remote
location. It is intended that Therajoy is used with common computer games which, it is
hoped, will be highly motivational for the person using it.
Another device that also fits into this category is TheraDrive. It consists of a modified
commercial force-feedback steering wheel that is used with customised and commercial
gaming software[67]. The commercial steering wheel is modified to extend its diameter
and so that customised forces can be applied during therapy, to resist or assist the
person using it. A low cost driving game (designed to build up driving skills in people
with brain injuries and learning disabilities) is used with the system and has been
considered to be fun and motivating by the subjects who used it in initial tests[68].

2.4.1.3. Complex	
  Robotic	
  Systems	
  
Two examples of complex robotic systems are MIT Manus, developed by a group in
MIT, Boston, USA, and Gentle/s, developed in the University of Reading in the UK.
MIT Manusis designed to administer robotic therapy to the should-elbow region of a
person’s arm. It first appeared in a journal paper written by Hogan et al. [7] in 1992 and,
since then, a large number of clinical trials have been conducted (see section2.5.4) and a
commercial version (called the In-motion Arm Robot) has been developed[69]. MIT
Manus operates primarily in the horizontal plane with only minimal, passive, movement
in the vertical plane [7]. The MIT Manus robot has been specifically designed to
administer robot therapy. The defining characteristic of the design is its extremely low
impedance achieved by the use of low impedance brushless motors in the design.
Impedance control is used as the control strategy (discussed Section 2.5.2.1). This is a
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control technique for robotic devices that physically interact with people and it gives the
device a soft, compliant feel [70]. As can be seen in Figure 2-2, the person using the
device sits in a chair at a table. Harnesses secure the person to the chair. This minimises
the movement of the persons upper body and thereby maximises the movement of the
shoulder-elbow region of the paretic arm during therapy. A computer monitor displays
an interactive environment for the person using MIT Manus to interact with. The
interactive environment prompts the person to use their arm to move the robot endeffector to a specific location. If the person cannot complete the movement on their
own, the robot will assist them in completing the movement [71].

Figure 2-2: A person using the MIT Manus shoulder and elbow rehabilitation robot. Figure taken from
[72].

Gentle/s, shown in Figure 2-3, is actuated by a commercial three degrees of freedom
haptic interface arm (Haptic Master) modified to accommodate a mechanism for
attaching it to a person’s wrist [73]. The entire system additionally consists of two
embedded computers, a monitor, speakers, seating for the person and an overhead arm
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support system[73]. It is a high impedance design when compared with MIT Manus. As
such, Gentle/s utilises an admittance control strategy (discussed in section 2.5.2.2). A
simplified block diagram of the control system used by the Haptic Master is shown
inFigure 2-4. The main thing to note from this is that the input from the person to the
control system is force and the output from the control system is position, velocity or
acceleration. When using Gentle/s, the individual’s arm is placed in an elbow orthotic,
with wires suspending it from an overhead frame to eliminate the effects of gravity.
Subjects using the system can exercise reaching movements in three degrees of freedom
through interaction with a virtual environment.

Figure 2-3: A person using the Gentle/s robotic rehabilitation system. Figure taken from [74].

Figure 2-4: A simplified block diagram of the admittance control system used in the Haptic Master.
Figure taken from [75].
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As with MIT Manus, a harness build into the person’s seat restricts the movement of the
torso and thus ensures that movements of the elbow-shoulder region are maximised and
that the subject isn't using other compensatory upper body movements to achieve a task.
Also, a magnetic connection device ensures that excessive forces can't be applied to the
persons arm. In the event of the applied forces exceeding a certain level, this magnetic
connection disconnects, severing the connection between the person and the robot.
Individuals practice reaching movements through interaction with a virtual room.
Examples of some of the virtual rooms that can be used with Gentle/s are shown
inFigure 2-5.The robot’s control software operates in three different modes[73]. Mode
1, passive therapy mode, is targeted at persons in the initial stages after having a stroke.
In this mode the robot teaches the person the correct movements by moving their arm to
the correct position. In mode 2, active-assisttherapy mode, the robot doesn't just move
the arm to the correct position but works with the user to help them complete the
movement. In mode 3 the robot only provides correction of movement direction.

Figure 2-5: Some of the virtual rooms available for Gentle/s. Figure taken from [74].
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2.5. Rehabilitation	
  Robots	
  

2.5.1. Motor	
  Adaption	
  
Humans can adapt their motor output to respond to new environments or changes in an
existing environment. As an example, consider a simple reaching task. The forces
required to actuate the arm can change in an often unpredictable way [76]. This could be
because there is a load being carried or because there is some external resistance to the
movement of the arm. The process through which the human motor system adapts to a
novel environment is called motor learning [76]. It provides flexible control that allows
a person to move with apparent ease, despite the uncertainty in their environment [76].
An understanding of motor adaption methods is essential for developing robotic devices
that act seamlessly with the human motor system. These devices fall generally into two
categories; assistive and therapeutic. Assistive devices aim to help a person complete a
task that they would not otherwise be able to complete. In this case it is desirable that
the robot takes over as much of the force production as possible while leaving
movement control to the user [77]. This, for example, could allow the user to walk with
heavier loads or move their arm in a way that they would otherwise be unable to do. On
the other hand, for therapeutic applications, high levels of effort from the individual
using the device are thought to be important, to build muscle strength and to facilitate
motor learning [78]. Therefore therapeutic robots aim to only provide “assistance as
needed”. This means that in completing a task, the force produced by the user should be
maximised and the force produced by the robot should be minimised. It is undesirable
that the robot takes over force production and thus eliminates the forces produced by the
user, as in assistive applications [77].
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2.5.1.1. Slacking	
  
Emken et al. [79] have proposed that when adapting to external force fields, the human
motor system seeks to minimise a cost function of both kinematic error and effort. They
showed that, because of this, when kinematic error is small, the human motor system
constantly attempts to reduce effort. If effort is thought of as being synonymous with
energy, the motor system can be thought of as constantly trying to reduce the energy
required to complete a task, which would seem logical. Emken et al. calculated a
discrete learning rule for the human motor system and arrived at the following equation:
𝑈!!! = 𝑓. 𝑈! − 𝑔. 𝑒!

(1)

Where 𝑈!!! is the effort to be expended on the next movement, 𝑈! is the effort
expended during the previous movement, 𝑒! is kinematic error during the previous
movement, 𝑓 is the forgetting factor and g is the learning gain. The forgetting factor
must always be between 1 and 0. Therefore, when kinematic error (𝑒! ) is small, 𝑓 acts to
reduce the effort to be expended on the next movement (𝑈!!! ). This phenomenon has
been called “slacking” by Reinkensmeyer et al. [77] and has implications for the design
of therapeutic robots.
Reinkensmeyer et al. [80] highlighted the implications of slacking for therapeutic robots
through the following case study. Consider a person attempting to complete a tracking
task, i.e. they attempt to use their arm to track the movement of a target. Based on
known aspects of human motor behaviour and incorporating a continuous version of
Equation 1, Reinkensmeyer et al. hypothesized that the continuous model of the human
motor control system for a task such as this is of the form:
𝑢 =    −𝑘! . 𝑒 − 𝑔! . 𝑒 − 𝑓! . 𝑢
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(2)

Where u is the effort generated by the human motor system and e is kinematic error.
The first term is a proportional controller with gain 𝑘! . The second term is an integral
controller with gain 𝑔! . Finally, the third term is a slacking term with a slacking rate 𝑓! .
Now consider that the persons arm is connected to a therapeutic robot. The robot aims
to assist the person is completing the task but because it is a therapeutic robot it also
aims to maximise the amount of force generated by the person while completing the
task. Now, consider three cases. In the first two cases the controller is a PID controller
that works by attempting to control the force generated by the robot in response to
kinematic error feedback. In the third case, the robot controller uses impedance control,
as per most robot rehabilitation devices.

Case 1: The robot controller doesn’t contain a slacking term (PID force controller)
If the human slacks and the robot does not, then over time the effort contributed by the
human to the task will decrease until eventually all force generation is done by the robot
[80].

Case 2: The robot controller contains a slacking term (PID force controller)
Now assume the robot does slack and 𝑔! /𝑓! ≪    𝑔! /𝑓! where 𝑔! is the integral gain of
the robot controller, 𝑔! is the integral gain of the human motor system, 𝑓! is the slacking
rate of the robot controller and 𝑓! is the slacking rate of the human motor system. In
steady state, the force generated by the human will approach its maximum [80]. If the
maximum force that the human can generate is less than that required to complete the
task then this robot with slacking will still generate the residual force necessary for the
task to be completed [80]. This controller tries to mimic what a therapist does when
he/she assists a person and would appear to be an ideal active-assist controller.
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Case 3: The robot doesn’t contain a slacking term (Proportional force controller i.e.
Impedance controller)
This case approximates the situation with most existing therapy devices [80]. If the
proportional gain of the robot controller (𝑘) is large (very stiff robot) and 𝑘 ≫    𝑔! /
𝑓! then both the tracking error and the effort contributed by the human to the task will
approach zero. On the other hand, if the proportional gain of the robot controller (𝑘) is
small (very compliant robot) and 𝑘 ≪ 𝑔! /𝑓! then the tracking error will also approach
zero but the effort contributed by the human to the task will approach the maximum.
However, while smaller values of 𝑘 are more effective at maximising the force
generated by the person, decreasing values of 𝑘 also reduce the ability of the robot to
assist the person if they are unable to complete the task (i.e. there is an increase in
kinematic error). Therefore, the selection of an appropriate value for 𝑘 is vital to
maximise the effectiveness of the active-assist action of this therapy.

For an ideal active-assist robot controller, it is vital to maximise the effort from the
person and at the same time minimise error. The situation described in case 2 is the
most effective at achieving this while the situation described in case 1 is the least
effective. The situation described in case 3 is a compromise whereby higher values for
the proportional gain lead to lower levels of kinematic error but also human effort and
vice versa.
An adaptive PID force controller proposed by Wolbrecht et al. [81] is presented in
Section 2.5.2.3. Wolbrecht et al. conducted several tests with this controller using the
Pneu-WREX robotic rehabilitation device. Eleven people in the chronic stage of poststroke recovery participated in the tests. Two separate experiments were conducted. The
first experiment confirmed that the adaptive controller/robot combination had the ability
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to help subjects’ complete the desired movements. The second experiment aimed to test
if the forgetting component of the controller led to the subject contributing a larger
proportion of work to the task. In the first part of this experiment, subjects moved their
arm from side to side in a horizontal plane, with the effect of gravity on their arm being
supported by the robot. The force required to move the arm was less than 2N. In this
case the effect of performing the task with or without the forgetting term was small. In
the second part of the experiment, the subject had to move their arm in the vertical plane
and had to overcome the weight of their own arm to do this, which was about 40N. In
this case the effect of including the forgetting term in the controller was found to be
significant. When the forgetting factor was present, the force output of the robot quickly
decreased to a level dependent on the individual’s movement ability i.e. the force output
decreased with the decreasing level of the subject’s impairment. However, when the
forgetting factor was not included in the controller, the force output from the robot
remained high, regardless of the subject’s impairment level. According to Wolbrecht et
al. [81], the results of these tests illustrate ‘slacking’ in the human motor system, i.e.
given the opportunity, a person will reduce his or her output, instead letting the robot do
the work for them. This is a phenomenon that must always be considered when
designing an active-assist therapy controller. Wolbrecht et al. intend to conduct a future
study comparing persons training on robots with two different forgetting rates. They
hope that this will effectively test the role of effort in recovery.

2.5.2. Control	
  Strategies	
  
In this section, different approaches to controlling post-stroke rehabilitation robots are
discussed, including the adaptive PID force controller proposed by Wolbrecht et al. [81]
referred to in Section 2.5.1.1. An overview of these different control strategies is shown
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in Figure 2-6. To begin, information is provided on impedance control and admittance
control, which are the most common control strategies in the literature.

Figure 2-6: An overview of the different control strategies used with rehabilitation robots. Impedance
control is the most popular means of providing assistance as needed to the person using the device.

Most rehabilitation robots aim to administer some form of active-assist therapy (see
section 2.3.1). The strategies of administering this vary, but many are based on the
premise that when the persons arm etc. deviates from a desired trajectory the robot
generates a restoring force which attempts to correct the person’s movement [82]. This
is called impedance based assistance. Controllers based on this approach provide
“assistance as needed” as they don’t intervene as long as the individual is moving their
limb along the desired trajectory or in a defined dead band around it. The dead band
accommodates the normal variability that occurs in human movement.
Determining a desired trajectory is crucial for implementing impedance based
assistance. When a person is using a rehabilitation robot, they are instructed to move
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their affected limb to a different location or along a path. This instruction is often given
through the medium of a simple game (MIT Manus) or virtual interactive environment
(Gentle/s) displayed on a monitor. The desired trajectory from the current position to
this new position can then be determined. There are a number of ways of doing this:
•

Using a mathematical model of normal trajectory, such as a minimum jerk
trajectory [82]

•

Pre-recorded trajectories from unimpaired people [82]

•

Pre-recorded trajectories from sessions of therapist guided assistance [82]

•

From the movement of an individuals unimpaired arm (as with BATRAC,
discussed in Section 2.2.3)

When robot therapy is being administered, the actual movement trajectory of the
individuals arm is compared to this desired trajectory. Then, depending on what
assistance algorithm is being used, if the person is unable to move their arm along the
desired trajectory, a force may be applied to the arm by the robot in an attempt to
correct this.
When using a robot for administering therapy, whether a robot is low impedance type or
high impedance type determines the control strategy that must be used with it. As a
generalisation, rehabilitation robots that are made of commercially available robotic
actuators will tend to be high impedance types whereas to achieve a low impedance
robot it will generally have to be custom made for the task. In general, impedance
control is an approach to impedance based assistance used with low impedance robots.
Admittance control is used with high impedance robots. Both, impedance and
admittance control are basic ways for interacting with a virtual environment [83] and
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have been used successfully to provide variable assistance to individuals using robot
rehabilitation systems [84].

2.5.2.1. Impedance	
  Control	
  
Impedance control was first proposed by Prof. Neville Hogan in 1984 [70]. An
impedance controller attempts to implement a dynamic relation between manipulator
variables, such as end-point position and force, rather than just control these variables
alone. The relationship between these variables is defined by the manipulator stiffness
such that:
𝐹 = 𝑘. (𝑥! − 𝑥)

(3)

where 𝐹  is the interaction force between the manipulator and the environment, 𝑘 is the
manipulator stiffness (set by the impedance controller), 𝑥! is the current position of the
manipulator and 𝑥 is the desired position of the manipulator. An example of a
therapeutic robot that uses an impedance control strategy is MIT Manus, discussed in
Section 2.4.1.3.
When used with therapeutic robotic devices, a desired trajectory for the persons arm is
generated. A visual display typically shows the person the current position of their arm
and the position of the target. If the person moves their arm along the desired trajectory
in a suitable manner, the impedance controller takes no action. However, if the person
deviates from the desired trajectory, the impedance controller will apply a correcting
force to move the arm back onto the desired trajectory. As per Equation 3, this force
will be a product of the distance from the desired trajectory and the stiffness of the
robot. Some implementations of impedance control also include a dead-zone around the
desired trajectory, to account for some levels of variance in typical human movement.
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When using impedance control, the user will feel all of the inertia and friction in the
system. Therefore, impedance control is particularly suited to low impedance robots
where the robot end-effector is easily moved by the user without any assistance from
the robot controller. Consider how a low impedance robot moves when the control
system is switched off. All of the motors, gearboxes etc. are back-drivable, so the robot
end-effector can be moved very easily. Low mechanical impedance is low resistance to
movement.Operationally, low impedance robots “get out of the way” as needed [85].
They therefore allow the person to freely express weak or uncoordinated movement if
appropriate. This feature may not be necessary for effective post-stroke rehabilitation
but it is considered to be important for obtaining uncorrupted measurements of
anindividual’s sensorimotor function [71, 85-88]. For high impedance robots, this is not
the case and therefore an admittance control strategy is considered to be more suitable.
Various adaptations of the impedance control approach have also been investigated.One
of these is triggered assistance[82]. In this approach, the gain of the standard impedance
controller is varied in response to a threshold of some trigger variable being breached.
For example, in a time triggered approach, if a person has not made sufficient progress
to the target in a specified time then the controller gain is increased so that the robot
provides more assistance to the person in completing the task. Alternatively, the
personcould use the robot without any assistance unless the trigger threshold is reached.
This form of assistance is designed to encourage the person to initiate movements
themselves, which is considered to be essential for motor learning [82, 89]. Trigger
variables that have been used include elapsed time, force generated by the participant,
limb velocity, tracking errors or muscle activity measured with skin surface
electromyography (EMG). Once assistance has been triggered the robot begins assisting
the person to complete the task. A danger that has been identified with using triggered
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assistance is that the person may produce initial forces or movement’s to activate the
trigger and then let the robot do the work for them to complete the task.

2.5.2.2. Admittance	
  Control	
  
In impedance control the input from the person is position and the output from the
controller is a force. On the other hand, in admittance control the input from the person
is a force and the output from the controller is a position or rate of change of position.
An admittance control strategy could be described according to the following function:
𝑑𝑥 = 𝑓(𝐹!"#$!% − 𝐹!"#$%"! )

(4)

Where𝑑𝑥 is the position trajectory and𝐹!"#$!% and 𝐹!"#$%"! are the measured and desired
interaction forces between the robotic manipulator and the environment [84].
Consequently, for a robot using admittance control, a force transducer is required for
each of the degrees of freedom in which the robot operates. These force readings must
subsequently be translated to human joint space co-ordinates using a forward kinematic
model of the robot actuator.
An example of a therapeutic robot that uses an impedance control strategy is
GENTLE/s, discussed in Section 2.4.1.3. A robot using admittance control, called
Haptic Master, is used as part of the Gentle/s system.A simplified block diagram of the
control system used in Haptic Master is shown in Figure 2-4 in Section 2.4.1.3. In this
case the human exerts a force on the robot end-effector, measured by a force transducer.
A virtual model then generates the position, velocity or acceleration that is a function of
this measured force. It will typically contain a virtual mass greater than zero to avoid
infinite accelerations. The control system then acts to realise the desired position,
velocity or acceleration.
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An admittance control strategy enables a person to move the end effector of a high
impedance robot with minimum effort. However, when used in therapeutic robotics, it
does not act to apply a correcting force to the persons arm if they stray from a desired
trajectory. In order to achieve this, it is necessary to build an impedance model into the
admittance controller’s virtual model. This then acts somewhat similar to an impedance
controller, generating a correcting force related to trajectory error. This correcting force
is added to or subtracted from (as appropriate) the force measured by the force sensor
before position, velocity or acceleration is calculated by the virtual model. This action is
perceived by the person as a feeling of increased resistance to movement as their arm
strays from the desired trajectory, as per impedance control.

2.5.2.3. Adaptive	
  PID	
  Force	
  Controller	
  
An issue with impedance controllers (and as a consequence also with admittance
controllers) is that as the controller stiffness increases the robot is better able to act to
reduce movement error (desirable) but at the same time the effort contributed by the
person to completing the task is reduced (undesirable). This is discussed in more detail
in Section 2.5.1.1. To combat this, Wolbrecht et al. [90] proposed an adaptive force
controller which aimed to be mechanically compliant, to have sufficient strength to
assist people in completing movements and also to only provide the minimum
assistance necessary during training. This controller has the form:
𝑅 = 𝑎 − 𝑘! . 𝑒 − 𝑘! . 𝑒

(5)

Where 𝑅 is the force applied by the robot to the persons arm, 𝑒 is kinematic error, 𝑘! is
the controller’s proportional gain (or stiffness), 𝑘! is the robot’s derivative gain (or
damping) and 𝑎 is an adaptive feed-forward term estimated by the update law:
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𝑎 =    −𝑓! . 𝑎 −    𝛤 !! (𝑒 +   𝛬. 𝑒)

(6)

Where 𝛤 and 𝛬 are positive gains used in the adaptive controller and 𝑓! is the robot’s
slacking rate (or forgetting rate) as discussed in Section 2.5.1.1. Combining the adaptive
controller and the update law gives the following equation:
𝑅 =    −𝑔! . 𝑒 − 𝑘! . 𝑒 − 𝑘! . 𝑒 − 𝑓! . 𝑅

(7)

Where 𝑔! = 𝑓! . 𝑘! +    𝛤 !! . 𝛬 and 𝑘! =    𝑘! +    𝛤 !! +    𝑓! . 𝑘! . A trial using this controller,
reported on by Reinkensmeyer et al. [80], showed that the controller successfully
learned to assist individuals with a range of severity of motor impairments. It was also
confirmed that incorporating the slacking term into the controller resulted in the person
contributing significantly more of the effort while keeping kinematic error small (see
Section 2.5.1.1).
Wolbrecht et al. [81] compared the performance of an adaptive controller with a
forgetting factor with a standard impedance controller. They stated that the compliant
adaptive controller gave less tracking error than would otherwise be possible with a
compliant (low impedance) standard impedance controller. Tracking error for the
impedance controller can be reduced by increasing the impedance, but then the robot
would become stiff and rigidly drive the person’s movements, which is undesirable.
However, a possible approach to reducing tracking error with an impedance controller is
to introduce a feed-forward term to compensate for the cause of the error (i.e. the weight
of the persons arm) but this would have to be continuously adjusted to accommodate the
increased ability of the person as they recover.
2.5.2.4. Electromyography	
  
Some studies have been done on the feasibility of using electromyography(EMG)
signals (i.e. electrical activity) from some muscles (i.e. pectoralis major, triceps, anterior
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middle and posterior deltoids, biceps, soleus, gastrocnemius) to trigger the assistance
provided by rehabilitation robots [91]. This could allow for the selection of specific
muscles to trigger the robot and could allow for targeted muscles to be trained,
according to the person’s needs. It may also allow the robot to be triggered earlier than
triggering based on kinematic measures and may allow very highly impaired individuals
to benefit from robot therapy. These persons may be able to generate EMG signals even
though they are unable to produce significant movement to trigger the robot.
While using EMG to control machines has been extensively investigated, using EMG
with rehabilitation robotics has been largely limited to monitoring pre-treatment versus
post-treatment changes in muscle activation [91]. A study conducted using MIT Manus
in 2005 investigated using EMG for triggering in robot therapy [91]. This study showed
that EMG could be used to trigger robot therapy however it concluded that further
research was necessary to validate the effectiveness of using this approach for robot
mediated therapy. Other studies have looked at generating assistance forces that are
proportional to the measured EMG [82, 92, 93]. With this approach the patient decides
what movement is to be performed.The robot then generates an assistance force
proportional to the measured EMG to compensate for any motor weakness that the
patient may have. There are some limitations with the use of EMG signals [82]. They
are sensitive to electrode placement, interference from neighbouring muscle signals and
skin properties. Therefore, an EMG based controller needs to be re-calibrated for each
individual and for each therapy session.
2.5.3. Motivation,	
  Difficulty	
  Balancing	
  and	
  Torso	
  Restraint	
  
Aside from how the robotic system will be controlled, there are other factors that have
to be considered for effective robot rehabilitation therapy. These considerations include
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patient attention and motivation, exercise difficulty balancing and torso restraint, which
are discussed in turn in the following paragraphs.
While attention and motivation are both subjective, they are considered to be key factors
influencing motor re-learning following a stroke [94-96].Most of the rehabilitation
robots discussed in this document achieve this through the use of a visual display that
individuals watch as they use the robot. This allows the person to play games or to use
the robot to interact with a virtual environment as they perform exercises.A study by
Loureiroet al. [73] in 2003 showed that subjects were motivated to exercise for longer
periods of time when they were using a mixture of haptic and virtual reality systems.A
key issue for many people with severe weakness after a stroke is the negative impact the
weight of their arm has on their ability to move it [97]. The current accepted approach
for encouraging active exercises in this situation is for the person to support their arm
on a table top and use a towel under the arm to reduce the friction between arm and the
table [97]. This approach has the advantages of being simple and inexpensive. In a
study by Reinkensmeyer et al.[97] from 2007, a group of eleven people undertook
standard table top therapy and also therapy with a device called T-WREX. T-WREX is
essentially an arm support device with sensors for facilitating active therapy. As with
most robotic therapy devices, T-WREX allows the person using it to play a game as
they undergo therapy. Through this medium it provides real time feedback to the person
on their progress. At the end of the trial there was found to be no difference in clinical
outcome between table top therapy and T-WREX therapy. However, questioning the
participants revealed that they preferred T-WREX therapy over table top therapy. While
they found table top therapy boring, T-WREX therapy was described as being more
interesting. Motivation is a particularly important consideration when exercises are
carried out in a domestic or non-specialist setting where supervision is minimal. It is
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therefore possible that if these people were practicing active therapy in, say, a domestic
setting, they would generally be motivated to do more therapy with T-WREX than with
a table top approach and more therapy leads to improved outcomes.
Another issue to consider is that if a person finds an exercise too difficult or too easy
then they may not be motivated to do the exercise for an extended period of time. One
approach to maintaining patient motivation throughout a course of rehabilitation therapy
was reported on by Zimmerli et al. [25] in 2012.

This approach consists of a

computational mechanism that adjusts the difficulty of an exercise for upper extremity
rehabilitation based on the empirical Fitts’ Law.
Fitts' Law:

𝑇 = 𝑎 + 𝑏. log ! (1 +   

𝐷
)
𝑊

(8)

Where 𝑇 is the time needed to move from start position to a target position, 𝑊 is the
size of the target, 𝐷 is the distance from the start position to the target and 𝑎 and 𝑏 are
person specific constants that are found empirically. Zimmerli et al. assumed that in
carrying out an exercise, a 100% success rate would lead to boredom while anything
below 50% would lead to frustration. Using Fitts’ Law, the average time it takes a
person to move from a start position to a target can be determined, dependent on both
the size and distance to the target. Therefore by setting a time limit on the movement,
Zimmerli et al. could give an initially challenging but at the same time not frustrating
exercise difficulty. Reducing the time allowed to reach the target was synonymous with
increasing the difficulty level.
Another feature common to shoulder-elbow robots is the use of some form of torso
restraint.Aperson typically sits in a chair in front of the robot and straps secure them to
the chair. The purpose of these straps is to minimise the movement of the torso while
robot therapy is being administered to the arm. This negates the person’s tendency to try
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and partially compensate for a deficiency in motor function of their arm through moving
their upper torso and thus maximises the movement of the arm.

2.5.4. Clinical	
  Trials	
  
In Section2.2.2, three different stages of post-stroke recovery are discussed; acute, subacute and chronic. In this section, clinical trials performed on people in each of these
stages are discussed.

2.5.4.1. Acute	
  Recovery	
  Stage	
  
There have not been a large number of trials conducted on people in the acute stage of
post-stroke recovery. It is particularly difficult to conduct clinical trials on these people
as such trials would have to be conducted almost immediately after a person is admitted
to hospital. As mentioned in Section 2.2.2, the emphasis at this stage is saving the
person’s life and preventing damage from occurring. However, two such trials were
reported on by Masiero et al. [16] and Rabadi et al.[17].
Masiero et al. [16] reported in 2007 on a trial involving thirty-five subjects in the acute
stage of post-stroke recovery. All had suffered a stroke less than one week before the
commencement of the trial. The subjects were divided into two groups, an experiment
group and a control group. The subjects in the experiment group received four hours of
robot therapy per week for five weeks. The robot exercised the shoulder/elbow region of
the upper limb. The subjects in the control group received 30 minutes of sham robot
therapy per week, also for five weeks. In addition, the subjects in both groups received
the same amount of standard rehabilitation therapy. At the end of the five weeks, the
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subjects in the experiment group showed significant improvement over those in the
control group, as measured by the FMA, MRC and FIM impairment metrics. When the
subjects were re-assessed three months after the end of the therapy and again after eight
months, these improvements were found to be sustained. It was also noted by Masiero
et al. that there were no adverse effects from the therapy and that the robot therapy was
well accepted by the trial subjects.
Another study was reported on by Rabadi et al. [17] in 2008. The study involved thirty
subjects who had suffered a stroke less than four weeks previously. The subjects were
divided into three groups: an occupational therapy group; an arm ergometer group and a
robot therapy group. An ergometer is an exercise machine that measures the amount of
work performed. All subjects received standard therapy as well as twelve additional
forty minute sessions of activity based therapy. At the end of the therapy, when the
subjects were assessed using the FMA, MSS and FIM impairment metrics, it was found
that the level of impairment was reduced across all of the groups and that there was no
difference between the subjects in the three groups.

2.5.4.2. Sub-‐Acute	
  Recovery	
  Stage	
  
There have been many studies conducted using subjects in the sub-acute stage of
recovery. The studies discussed here were conducted by Aisen et al. [18], Volpe et al.
[19] and Lum et al. [21].
An early clinical trial was reported on by Aisen et al.[18] in 1997, using the MIT Manus
rehabilitation robot. It involved twenty subjects and showed that using robotic
rehabilitation devices may favourably add to recovery and that there were no adverse
effects for subjects using the robotic rehabilitation device.
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Volpe et al. [19] reported on a larger trial, also conducted using MIT Manus, in 2000.
This trial involved 56 people with upper limb weakness in one of their arms, who had
suffered a single unilateral stroke within four weeks of their admission to the study.
Subjects were randomly divided between an experimentgroup and a control group. The
experiment group received 4-5 hours per week of therapy on top of a course of standard
manual rehabilitation therapy while the control group received 1 hour per week of robot
therapy on top of a course of standard manual therapy. Everybody in the experiment
group received at least 25, one hour sessions of robot therapy. By the end of treatment,
the experiment group demonstrated a greater improvement than the control group when
assessed using the MRC, MSS and FIM impairment metrics. This difference was
attributed to the extra robotic therapy that was administered to the experiment group.
The significance of this trial is that it was one of the earliest to demonstrate the potential
of robotic therapy to illicit improvement in post-stroke persons.
Another clinical trial was conducted by Lum et al. [21] in 2006 using the MIME
rehabilitation robot device. The purpose of this trial was to confirm the results of a
previous trial conducted on chronic stroke patients, discussed in Section 2.5.4.3. Thirty
subjects took part in the trial and received fifteen, one hour therapy sessions over a
period of four weeks. The MIME robot operates in two modes, standard mode and
bilateral mode. Standard mode uses an admittance control strategy while in bilateral
mode the individual using the robot can use their ‘good’ arm to control the motion of
their paretic arm. Subjects were divided between three robot groups and a control group.
One robot group used MIME in standard mode, one robot group used MIME in bilateral
mode and the third robot group used MIME in a combination of the two modes. The
subjects in the control group received equally intensive amounts of conventional
neurodevelopment therapy. It was found that at the end of all the therapy sessions, the
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subjects in the three robot groups had significantly greater gains in the FMA scores for
their shoulder/elbow than the control group. However, this finding is compromised by
the findings of a study reported on by Hafsteinsdottir et al. [98]. In this study involving
324 participants it was found that neurodevelopment therapy approach was not as
effective in the care of stroke patients in a hospital setting as a standard
approach.Examination of gains in individual subjects suggests the robotic treatment is
most effective for subjects in a middle range of motor impairment. Therefore, while this
study confirms the results of previous studies in showing motor function gains from a
course of robot administered therapy; it does not demonstrate that robot therapy is
superior to other rehabilitation approaches in terms of eliciting decreases in motor
impairment. Also, when the results across the three robot groups were compared it was
found that people who used the robot only in bilateral mode made smaller gains than
those in the other two groups, suggesting that this approach to rehabilitation is suboptimal [99].

2.5.4.3. Chronic	
  Recovery	
  Stage	
  
The majority of robot therapy studies have been conducted on persons in the chronic
stage of recovery. This may be because it is relatively easier to recruit people in this
category for a study as opposed to people in the sub-acute stage and particularly in the
acute stage of post-stroke recovery. The studies discussed here were conducted by Lum
et al. [28], Krebs et al. [32] and Lo et al. [37].
Lum et al. [28] conducted a trial in 2002 using the MIME robotic rehabilitation device
that aimed to compare a program of robot therapy with an equally intensive program of
conventional therapy. Twenty-seven people with chronic stroke received twenty-four,
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one hour therapy sessions over a period of two months. It was a pre-requisite and had
similar results to the trial conducted on sub-acute persons, discussed in Section 2.5.4.2.
Another study by Krebs et al. [32] was conducted in 2008 using the MIT Manus robotic
rehabilitation device. This trial was conducted using forty-seven subjects and aimed to
compare the improvement from training the movement of the arm and grasping an
object with training the movement of the arm in isolation. From the results of this trial,
Krebs et al. concluded that training the movement of the arm and grasping an object
yielded no advantage over training the movement of the arm in isolation. They also
further re-enforced previous findings that goal directed robotic therapy can significantly
improve the motor function abilities of the exercised section of the limb of people in the
chronic stage of post-stroke recovery. This last finding is further emphasised by the
findings of trials conducted by, amongst others, Posteraro et al.[36] in 2009 using MIT
Manus, Bovolenta et al. [35] in 2009 using the ReoGo system, Rosati et al.[22] in 2007
using the NeReBot system, Fazekas et al.[100] in 2007 using the REHAROB system
and Fasoli et al.[29] in 2003 using MIT Manus.
A follow-on trial from the one by Krebs et al. was conducted by Lo et al. [37] in 2010,
also using MIT Manus. It involved one hundred and twenty seven people with moderate
to severe upper limb impairment who were divided into three groups. Forty nine were
assigned to a robot therapy group, fifty were assigned to a group that received similar
amounts of intensive therapy as the robot therapy group and twenty eight were assigned
to a group that received standard rehabilitation therapy. Therapy was administered for
thirty-six, one-hour sessions over a period of twelve weeks. When subjects were
assessed at the end of all of the therapy sessions, it was found that the people in the
robot therapy group showed greater improvement than the standard therapy group, as
measured using the FMA, Wolf Motor Function Test and Stroke Impact Scale
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impairment metrics. However, the improvement in the robot therapy group was found to
be slightly worse than for those in the intensive therapy group. All of the subjects were
re-assessed six months after the trial and it was again found that while the robot therapy
group showed significant improvement over the standard therapy group, there was no
significant difference between the robot therapy group and the intensive therapy group.
This again reinforces previous findings that while a course of robot administered
therapy can elicit significant motor function improvements, these improvements are not
superior to those resulting from an equally intensive manual approach.
Finally, a further part of the trial by Lo et al[37]was a cost analysis of the three
rehabilitation methods employed. For the twelve-week trial it was found that the
average cost per participant was $9,977 for people in the robot therapy group and
$8,269 for people in the intensive comparison therapy group. After thirty-six weeks, it
was found that the total cost of therapy and all other healthcare use costs was $15,562
for the robot therapy group, $15,605 for the intensive comparison therapy group and
$14,343 for the standard therapy group.

2.6. Discussion	
  of	
  Literature	
  Review	
  

The more therapy a person receives the greater their increase in motor function. Robot
mediated therapy is an approach to administering intense rehabilitation therapy to
people. In general, robotic rehabilitation systems are well accepted by people and robot
mediated therapy has few negative side effects on individuals. This is backed up by
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clinical trials reported on by Masiero et al. [16] and Aisen et al. [18]. Robot mediated
therapy has also been found to have a positive effect on a person’s motor function
whether that person is in the acute, sub-acute and chronic stage of post-stroke recovery.
This is backed up by a number of the clinical trials discussed in Section 2.5.4.3,
including those reported on by Masiero et al. [16], Volpe et al. [19] and Krebs et al.
[32]. Generally, it can be said that intensive movement therapies, of the type delivered
by robotic rehabilitation devices, are capable of producing significant and sustained
gains in motor function in people with upper limb impairment post-stroke.
However, there is a caveat to this. To date, the majority of studies have found that robot
mediated active-assist therapy is no more effective than an equally intensive course of
manually administered active-assist therapy. This is supported by clinical trials reported
on by Rabadi et al. [17] and Lo et al [37]. Therefore, there is insufficient evidence to
suggest that an improvement in a person’s movement ability from a course of robotmediated therapy is due to the particular nature of robot-mediated therapy rather than
simply the additional therapy provided.
While robot therapy cannot be considered a panacea for post-stroke limb rehabilitation,
the evidence to date does point to some potentially useful applications for this
technology. The ability of robot mediated therapy to elicit motor function improvements
similar to intensive conventional therapy and particularly the motivational aspects of
this therapy (discussed in Section 2.5.3) point to potentially useful applications in local
clinic or domestic settings. Rehabilitation devices for a domestic or local clinical setting
can be used more regularly and over a longer period of time for less cost than an
equivalent device in a hospital or specialist rehabilitation clinic. More regular intensive
therapy will result in better motor function outcomes for post-stroke individuals as,
according to Fasoli et al. [101], the course of stroke recovery may be more related to the
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cessation of exercise and inadequate attempts to functionally use the paretic limb than to
neural barriers that cannot be overcome.
Currently, the cost of complex robotic devices makes them unsuitable for use in a
domestic or local clinical setting. Developing lower cost devices could help to address
this and the development of a prototype low cost robotic device for post-stroke
rehabilitation in a local clinic or domestic setting is the focus of this project. Passive
devices with sensors, such as smart-phones with specialist software, to assist in
administering active therapy could fit this role, as well as more traditional approaches
such as constraint induced movement therapy. However, both of these approaches are
more suitable for people with less severe upper limb motor impairments. People with
moderate or severe impairments may have difficulty supporting the mass of their own
arm under the effects of gravity and thus need some form of arm support before they
can begin therapy. Passive devices are also unable to come to the aid of moderately or
severely impaired individuals when they are unable to complete a designated movement
unassisted. In a local clinic or domestic setting, the person undergoing therapy may be
relatively unsupervised and there may be no experienced therapist available on a regular
basis. Therefore, there are some practical issues surrounding the use of a robotic therapy
device in this environment including user safety, ease of device setup, remote progress
assessment and remote interaction between therapists and patients [10].
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Chapter 3

Description of Design

3.1. Therapy	
  Platform	
  Functional	
  Requirements	
  

A physical design and build was decided on by the research team as the appropriate
method of approach for answering the research question presented in Section 1.2.
Following on from this, a number of requirements were defined outlining the basic
high-level functionality of the therapy platform to be developed. These functional
requirements were devised by the research team based on the information presented in
the literature review (Chapter 2) and following consultations with the stroke
rehabilitation group in NUI Maynooth and with rehabilitation professionals from Enable
Ireland. They are detailed as follows:
•

The therapy platform shall administer post-stroke therapy to the shoulder and elbow
joints of the upper limbs.

•

The therapy platform shall facilitate the performance of active rehabilitation
therapy.

•

The therapy platform shall be capable of assisting in the performance of activeassist rehabilitation therapy.
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•

The therapy platform shall be capable of supporting the person’s arm against forces
due to gravity.

•

A motivational display shall be incorporated into the therapy platform.

•

The cost of the therapy platform shall be minimised.

•

All mechanical, electronic and software systems shall be designed such that any
system failure causes the device to stop in a safe manner.

3.2. Design	
  Overview	
  

An image of the completed therapy platform is shown in Figure 3-1. It is designed to
operate on a table top. The person using the therapy platform sits on a chair in front of
it. Their arm is then secured to the arm orthotic with two Velcro straps. Open cell foam
under their arm is used for comfort.
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Game
Display

Control
Computer

Arm
Orthotic

Figure 3-1: Photograph of the completed therapy platform.

The therapy platform can be used to administer active or active-assist upper limb
rehabilitation therapy. During active therapy, the person looks at the game display and
moves their arm to interact with the game. The game display will log the person’s
performance and give them real-time feedback on how well they have performed the
exercise. For active assist therapy, the therapy platform will operate in the same way but
in addition will apply forces to the persons arm to help them to complete the required
movement if they are unable to complete it in a satisfactory manner unassisted. The
operational settings of the therapy platform can be set using the control computer. An
overview of the therapy platform sub-systems is given in Figure 3-2. The design of the
therapy platform will be discussed under three headings: Mechanical Design, Electronic
Design and Software Design. A bill of all of the materials used in the construction of the
therapy platform is then given in Section 3.6.
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Figure 3-2: Overview of therapy platform systems and sub-systems.

3.2.1. Device	
  Safety	
  and	
  Ethical	
  Issues	
  
Safety and ethical issues are of the utmost importance for any device intended for use
with people. This is especially true when dealing with post-stroke individuals, who may
be particularly vulnerable. As such, before the commencement of this research project,
ethical approval was sought and gained from the DIT Research Ethics Committee.
Considerable attention has been given to safety throughout the design of the therapy
platform. In particular, the electronic and software systems were designed to be as far as
possible fail-safe. In the context of this design the most significant risk to the user is
from excessive force being administered to their arm by the motors that actuate the
device. Therefore, fail-safe here requires that there is no power to these motors in the
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event of a malfunction. A number of medical device standards are maintained by the
International Standards Organisation (ISO), including ISO14971:2007 (Medical
Devices – Application of Risk Management to Medical Devices).

As the design

described in this chapter is intended as a prototype, the device has not been designed
strictly in accordance with these standards.

3.3. Mechanical	
  Design	
  

This section outlines the construction of the therapy platform assembly and describes all
of the components used.

3.3.1. Mechanical	
  Design	
  Overview	
  
An isometric view of a solid model of the therapy platform is shown in Figure 3-3. The
solid model was created using SolidWorks 2011 software. The overall height of the
therapy platform is 320mm, the width is 690mm and the length is 620mm.
The therapy platform can move with three degrees of freedom (DOF) as shown in
Figure 3-3. This is similar to the functionality of MIT Manus, discussed in Section
2.4.1.3. DOF 1 and DOF 2 allow the therapy platforms end-effector to move in a
horizontal plane of dimensions 300mm by 300mm. These dimensions keep the device
compact while still allowing for a sufficient operating envelop for the arm of the person
using the device. Electrical motors can actuate the therapy platform in these DOF’s,
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creating a Cartesian robotic system. Cartesian robotic systems have simpler forward and
reverse kinematics when compared to other robot architectures. DOF 3 is passive and
accounts for changes in the users elbow angle as an individual moves their arm through
the movement envelope defined by DOF 1 and DOF 2.
The therapy platform is composed of three sub-assemblies: 001, 002 and 003. These are
shown in the exploded view of the therapy platform, Figure 3-4.

1
3

2

Figure 3-3: Therapy platform assembly.
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003

002

001

Figure 3-4: Exploded view of the full therapy platform assembly with the part numbers of the main subassemblies labelled.

3.3.2. Sub-‐Assembly	
  001	
  
A solid model of sub-assembly 001 is shown in Figure 3-5. An exploded view of subassembly 001 is shown in Figure 3-6. A description of each of the parts labelled in
Figure 3-6 can be found in the bill of materials included in Appendix C.
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Figure 3-5: Sub-Assembly 001.

001-015
001-013

001-010

001-008

001-014
001-007
001-009

001-002
001-012

001-011

001-001

001-003
001-006

001-004

001-005

Figure 3-6: Exploded view of Sub-Assembly 001 with component part numbers labelled. A description
and details of the manufacture of each part can be found in the bill of materials, Appendix C.
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3.3.3. Sub-‐Assembly	
  002	
  
An isometric view of a solid model of sub-assembly 002 is shown in Figure 3-7. An
exploded view of sub-assembly 002 is shown in Figure 3-8. A description of each of the
parts labelled in Figure 3-6 can also be found in the bill of materials included in
Appendix C.

Figure 3-7: Sub-Assembly 002.
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002-004
002-005

001-017
002-007

001-018

002-003
002-006

001-019
001-016
002-002

002-001
002-009
002-008
002-010

Figure 3-8: Exploded view of Sub-Assembly 002 with component part numbers labelled. A description
and details of the manufacture of each part can be found in the bill of materials, Appendix C.

3.3.4. Sub-‐Assembly	
  003	
  (Arm	
  Orthotic)	
  
A solid model of sub-assembly 003 (the arm orthotic) is shown in Figure 3-9. A
person’s arm rests on top of the arm orthotic. Open cell foam is placed on the top face
on the arm orthotic for reasons of comfort. Two Velcro straps are used to secure the arm
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in position. These are not shown in the solid model. An exploded view of sub-assembly
003 is shown in Figure 3-10. A description of each of the parts labelled in Figure 3-6
can be found in the bill of materials included in Appendix C.

Figure 3-9: Sub-Assembly 003.

A force sensor (part number: 003-018) is integrated into sub-assembly 003. As the
person attempts to move their arm, forces are transmitted to the force sensor. This is
similar to the operation of Gentle/s, discussed in Section 2.4.1.3. Sub-assembly 003 is
designed to transfer only some of these forces directly to the force sensor. This is
illustrated by Figure 3-11. In this figure, the green arrow represents forces that are
transferred to the force sensor. It is desirable that the forces applied in the directions of
the red arrows are not transferred to the force sensor. These forces are primarily due to
the weight of the person’s arm as it rests on the therapy platform.
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003-014

003-013

003-007

003-011

003-012

003-010

003-006

003-016

003-009
003-017
003-005
003-003

003-001

003-002

003-018

003-015

Figure 3-10: Exploded view of Sub-Assembly 003 with component part numbers labelled. A description
and details of the manufacture of each part can be found in the bill of materials, Appendix C.
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Sub-assembly 003 has been designed to minimise the effect of these forces (and the
torques that result from them) on the force sensor. This is achieved through the use of
roller bearings (part number: 003-006). The top most section of sub-assembly 003 is
connected through a bushing and shaft to the force sensor. The roller bearings do not
inhibit the movement of this top section in the horizontal plane. Thus, any force applied
in this plane is directly transmitted to the force sensor. However, any forces applied
perpendicular to this (i.e. in the direction of one of the red arrows) are transferred
though the roller bearings to the therapy platform frame.

Roller Bearing
(003-006)

Figure 3-11: Principal of operation of Sub-Assembly 003. The construction of sub-assembly 003
minimises the effect on the force sensor of forces applied in the direction of the red arrows and maximises
the effect on the force sensor of forces applied in the direction of the green arrow.
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3.4. Electronic	
  Design	
  

3.4.1. Electronic	
  Design	
  Overview	
  
Figure 3-12 shows the sub-systems that make up the therapy platforms electronic
system and how they interact with one another. The majority of the sub-systems are
housed inside a plastic electronics enclosure (part number: 005-027) to protect them
from interference and damage. Most of the electrical circuits described in the following
sections are implemented on a breadboard (part number: 005-026) inside this electronics
enclosure. Using a breadboard allowed for fast prototyping of electronic circuits and for
alterations to be made to these circuits with ease. As the breadboard is protected from
interference inside the electronics enclosure it was not thought necessary to implement
the breadboard circuit on a Printed Circuit Board (PCB) for the purpose of this
prototype.

.
Figure 3-12: Therapy platform electronic sub-systems
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3.4.2. Control	
  Computer	
  
The control computer sub-system is shown in Figure 3-13 and a photograph of the
therapy platform with the control computer components labelled is shown in Figure
3-14. The control computer sub-system consists of two components: a LCD monitor and
a laptop computer. The LCD monitor is connected to the laptop computer using the
computers VGA port. The laptop computer is also connected to the motor control subsystem and the microcontroller sub-system through USB ports. Both the LCD monitor
and the laptop computer are powered from a 240V AC mains socket via manufacturer
provided power supply modules.

Figure 3-13: Control Computer Sub-System
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LCD Monitor
Laptop Computer

(005-002)

(005-001)

Figure 3-14: A photograph of the therapy platform with the control computer sub-system components
labelled.

3.4.3. Microcontroller	
  
The microcontroller sub-system is based on an Arduino UNO (part number: 005-005).
The Arduino UNO is an open-source microcontroller board based on the Atmel
ATmega328 microcontroller. It has, amongst other features, 14 digital input/output pins,
6 analogue inputs, a 16 MHz crystal oscillator and a USB connection (standard type B).
A schematic of the Arduino UNO and a datasheet for the ATmega328 microcontroller
are given in Appendix
The Arduino UNO is secured in position inside the electronics enclosure and all
connections to it are made through the main breadboard (part number: 005-026). The
exception to this is the USB connection with the control computer sub-system. This is
made using a short USB standard type A to USB standard type B cable (part number:
005-028) that connects the USB socket on the Arduino UNO to one of the native USB
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ports on the laptop computer. This provides power to the Arduino and facilitates serial
communication between the microcontroller and the laptop computer.

3.4.4. Microcontroller	
  Peripherals	
  
The microcontroller peripherals sub-system is shown in Figure 3-15. It consists of four
LED’s and an emergency stop button; all connected to the digital I/O ports of the
microcontroller. The emergency stop button is a Single Pole Single Throw (SPST) type.
The four LEDs are each connected in series with a 250Ω resistor. These limit the
amount of electrical current flowing through each LED to about 17mA. These four
LEDs protrude through the cover of the electronics enclosure. Underneath the cover,
these LEDs, along with their associated resistors, are soldered to a 30mm x 50mm
electrical strip board (part number: 005-029). A male, 15 way, right angle, D-Sub
connector (part number: 005-030) is also soldered to this strip board. A cable harness
(part number: 005-032), with a female, 15 way D-Sub connector (part number: 005031) at one end, is used to connect this strip board to the main breadboard inside the
electronics enclosure. The LEDs are then connected to the microcontroller through the
main breadboard (part number: 005-026). The D-Sub connectors allow for the LEDs to
be disconnected if the lid of the electronics enclosure has to be removed.
Finally, the emergency stop button is connected to the microcontroller through the
breadboard and a 2m long, two-core, sheathed cable (part number: 005-033). This cable
passes through a cut out in the electronics enclosure and allows for the emergency stop
button to be place in a suitable position when the therapy platform is in use.
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Figure 3-15: Electrical connection diagram of the microcontroller peripherals sub-system.

3.4.5. Force	
  Sensor	
  
The force sensor sub-system is shown in Figure 3-16. Force is measured by a Futek biaxial force sensor. This measures force along two axes and operates using strain gauges
organised in a Wheatstone bridge. It is integrated into mechanical sub-assembly 003,
discussed in Section 3.3.4. The remainder of the circuit is implemented on the main
breadboard (part number: 005-026) inside the electronics enclosure (part number: 005027). Two long, shielded, 4 core cables (part number: 005-025) are used to connect the
force sensor to the rest of the circuit, one for each axis. These cables supply +5V and
ground connections for exciting the force sensor and carry back analogue force signals
to the differential instrumentation amplifiers.
The instrumentation amplifiers amplify the small output signals from the force sensor to
a range of 0-5V. Their respective amplification gains are set by 200Ω resistors (part
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number: 005-019) to a value of 1005. In addition, a set-point voltage of 2.5V is
provided to each amplifier. Therefore, when there is no output from the force sensor, the
output each amplifier is 2.5V. If a force is applied to the force sensor in the +X direction
the output from the relevant amplifier will increase above 2.5V and if a force is applied
to the force sensor in the -X direction the output from the relevant amplifier will
decrease below 2.5V. Finally, a first order low pass filter is implemented on the output
line from each of the instrumentation amplifiers to remove high frequency noise from
the signal. The half power frequency of both of these filters is set to 80Hz.

Figure 3-16: Electrical connection diagram of the force sensor sub-system.
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3.4.6. Motor	
  Control	
  
The motor control subsystem is shown in Figure 3-17. It controls two Maxon
Electronically Commutated (EC) motors. Each of the EC motors is controlled by a
dedicated Maxon EPOS motor controller. Eight core cables (part number: 005-038) are
used to connect the motors to the motor controllers. Signals from Hall sensors built into
each of the motors are fed back to its motor controller. These signals are used by the
motor controller to implement closed loop position or speed control of the motor. The
motor controller can also directly control the current sent to the motor. Commands are
sent from the control computer to the motor controllers through a Controller Area
Network (CAN) bus, using the CANopen protocol. The motor controllers have built in
CAN functionality however, as the control computer does not have a native CAN port,
it is connected to the CAN network through an IXXAT USB-to-CAN interface.
Power for the motors and motor controllers is provided from the power sub-system. As
a safety feature, a p-channel Metal Oxide Semiconductor Field Effect Transistor
(MOSFET) on this connection is used as a switch that allows power to the motor
controllers to be turned on and off. This MOSFET is controlled by the microcontroller
sub-system, via an opto-coupler. The opto-coupler is required because of the different
operating voltages of the MOSFET and the microcontroller. In the event that the
emergency stop button is pressed, the microcontroller will immediately shut off power
to the motors and motor controllers. The motor controllers and USB-to-CAN interface
are both mounted inside the electronics enclosure (part number: 005-027). One of the
motors is integrated into mechanical sub-assembly 001; the other motor is integrated
into mechanical sub-assembly 002. This is discussed in Section’s 3.3.2 and 3.3.3. All of
the remaining components are implemented on the main breadboard (part number: 005026) inside the electronics enclosure.
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Figure 3-17: Motor Control Sub-System

3.4.7. Power	
  
The power sub-system is shown in Figure 3-18. It consists of a Single Pole Single
Throw (SPST) ON/OFF Switch and a power supply module. Power to the power supply
module is provided at 240V AC from a mains socket. The power supply then steps
down and rectifies this power input to provide power at +24V DC and up to 10A to the
motor control sub-system. The ground connection on the output from the power supply
is connected to the common electrical system ground.
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The ON/OFF switch is mounted in the side of the electronics enclosure (part number:
005-027). The power supply is located outside the electronics enclosure and is
connected to it, and hence to the motor control sub-system, through two short cables
(part numbers: 005-034 and 005-035) and 4mm sockets (part numbers: 005-036 and
005-037) mounted in the skin of the electronics enclosure.

Figure 3-18: Power sub-system.

3.5. Software	
  Design	
  

3.5.1. Software	
  Design	
  Overview	
  
Figure 3-19 shows the therapy platforms software system. The two main software subsystems are the microcontroller software and the control computer software.

3.5.2. Serial	
  Communication	
  Protocol	
  
Serial communication (baud rate of 115,200 baud/s) is used between the microcontroller
and the control computer. For this, a TTL level serial port on the microcontroller is
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used. A UART integrated into the microcontroller provides a hardware buffer for
storing received data until it can be processed by the microcontroller.

Figure 3-19: An overview of the therapy platforms software system.

However, the laptop used as the control computer does not have a native serial port.
Hardware integrated into the Arduino UNO microcontroller board acts as a USB-toSerial interface. Serial data to and from the microcontroller can therefore be sent to the
control computer through the Arduino’s USB port. Driver software on the control
computer then makes the connection with the Arduino available in the form of a ‘COM’
port. This driver software also creates a software buffer for storing received data on the
control computer until it can be processed.
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A handshake protocol is used to regulate the communication between the control
computer and the microcontroller. As the software on the control computer and the
software on the microcontroller run at different speeds, using a handshake protocol
ensures that data will not build up in either the control computer or microcontroller
buffers, which would lead to unacceptable system lags. For the handshake protocol, the
control computer is designated as the master and the microcontroller is designated as the
slave. The microcontroller sends data packets to the control computer in response to
commands received from the control computer. Generally, only one data packet is sent
for each command byte that is received. Table 3-1 details the different commands that
can be sent from the control computer to the microcontroller. Table 3-2 shows the data
packets that can be sent from the microcontroller to the control computer.

Instruction to Microcontroller

Command Byte

Send a force data packet

‘\x01’

Transition to STOP state (power off motor

‘\x02’

controllers)
Table 3-1: The commands that can be sent from the control computer to the microcontroller. The values
in the Command Byte column are given in ASCII code.

Packet Description

Sync Byte

Packet I.D.

Data Bytes

Byte
Force data

‘\x02’

‘\x05’

state + FX_highbyte + FX_lowbyte +
FY_highbyte + FY_lowbyte + checksum

Stop Flag

‘\x02’

‘\x82’

Force Threshold

‘\x02’

‘n’

‘\x02’

‘x’

Exceeded Flag
Emergency Flag

Table 3-2: The structure of the different packets that can be sent by the microcontroller to the control
computer. The values in the Sync Byte and Packet I.D. columns are given in ASCII code.	
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3.5.3. Microcontroller	
  Sub-‐System	
  
The microcontroller software runs on an Atmel ATmega328 microcontroller on an
Arduino UNO microcontroller board. This microcontroller is loaded with the Arduino
boot loader and is programmed using the C programming language using Arduino
libraries. The basic purpose of the microcontroller is to allow the control computer to
interface with the external force sensor and other input/output devices. A flow diagram
of the microcontroller software is shown in Figure 3-20. It is implemented as a version
of a finite state machine. There are four possible states: WAIT, RUN, STOP and
EMERGENCY.

Figure 3-20: Simplified flow diagram of the microcontroller software
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When the microcontroller is powered on its digital ports are initialised. Five digital
ports are set as outputs and one is set as an input. Of the five output ports, four (9, 10,
11, 12) control the LED’s described in Section 3.4.4. These are all initially set to high
(LED’s switched on). The fifth output port (7) controls power to the motor controllers
(as discussed in Section 3.4.6). It is initially set to high (motor controller power on). The
single digital input port (4) reads the input from the emergency stop button. An internal
pull up resistor is set so that the input to this port is high when the emergency stop
switch is open. After the digital ports have been initialised, the microcontrollers
integrated UART is also initialised at a baud rate of 115,200 baud/s. This starts serial
communication with the control computer sub-system. The state is then set to WAIT.
The microcontroller software then enters a loop. A different function is executed on
every loop depending on the state value. A flow diagram of the WAIT function is
shown in Figure 3-21. In this state, the digital ports are configured such that only the
green LED (port 10) and the power to the motor controllers (port 7) are switched on. A
command is sent from the control computer to the microcontroller to signify that the
control computer is ready to receive data. The microcontroller’s serial buffer is checked
to see if this command has been received. If so the state is set to RUN. Otherwise, the
program remains in the WAIT state.
A flow diagram of the RUN function is shown in Figure 3-22. In this state, the digital
ports are configured such that only the blue LED (port 11) and the power to the motor
controllers (port 7) are switched on. The current values of the outputs from the force
sensor are then read through two of the microcontroller’s analogue ports (A0 and A1) at
a resolution of 10bits. These values are later multiplied by a calibration constant using
the control computer software to give actual force values. A handshake protocol has
been implemented to regulate the serial communication between the microcontroller and
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Figure 3-21: Simplified flow diagram of the microcontroller WAIT function

Figure 3-22: Simplified flow diagram of the microcontroller RUN function
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the control computer. This is discussed in more detail in Section 3.5.2. As such, the
microcontroller only sends a data packet if it has first received an appropriate command
byte from the control computer (‘\x01’). If any other command byte is received (i.e.
‘\x02’) then a ‘Stop Command Flag’ is set and the program transitions to the STOP
state. Likewise, if the emergency stop button is pressed an ‘Emergency Flag’ is set and
the program transitions to the STOP state and if the force value exceeds a predefined
threshold a ‘Force Threshold Flag’ is set and the program again transitions to the STOP
state.
A flow diagram of the STOP function is shown in Figure 3-23. In this state, the digital
ports are configured such that only the red LED is switched on. The power to the motor
controllers is switched off. The action taken by the program is then determined by what
flag is set in the RUN function before the transition to STOP. If the Force Threshold or
Emergency flags were set then the STOP function sends ten data packets through the
serial port giving the flag status and telling the control computer that the microcontroller
is about to stop. The state then transitions to EMERGENCY. However, if the Stop
Command flag is set, the microcontroller sends ten packets through the serial port
indicating the flag status and transitions to the WAIT state, where it waits for a new
command byte from the control computer.
Finally, in the EMERGENCY state, the digital ports are configured such that only the
red LED is switched on. The power to the motor controllers is switched off. The
program then runs in a continuous loop in this state. The EMERGENCY state can only
be escaped by resetting the power to the microcontroller.
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Figure 3-23: Simplified flow diagram of the microcontroller STOP function

3.5.4. Control	
  Computer	
  Sub-‐System	
  
All of the custom control computer software is written using the Python programming
language (CPython 2.7). C or C++ are probably the most widely used languages for this
type of application. One of the disadvantages of using Python over C/C++ is its slightly
slower execution speed. This is because Python is an interpreted language (C/C++ are
compiled languages) and therefore uses more system resources when the program is
being executed. However, as there are ample control computer system resources
available, this disadvantage is more than compensated for by some of the advantages of
using Python over C/C++. The design philosophy of Python emphasises code
readability and code efficiency. As such, Python facilitates much quicker application
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development than using C/C++. Python also comes with a large standard library and
many modules from this and other third party modules were used for this project. These
are detailed in Table 3-3. Also, Python is itself written in the C programming language.
As such libraries (i.e. for communicating with the motor controllers) written for use
with C/C++ can also be used with Python. Furthermore, the execution speed of the
program can be increased using tools such as Pyrex, which compiles Python code into C
code (it is not necessary to do so for this application).

Python Module

Used In

Function

ctypes

Robot thread

Provides C compatible data types and allows calling
functions in DLLs or libraries written in C.

math

Main, Robot thread,

Provides access to mathematical functions.

Game sub-process
multiprocessing

Main, Game sub-

Supports spawning processes using an API similar to

process

the threading interface.

numpy

Robot thread

Facilitates scientific computing with Python.

os

Main, Game sub-

Handles miscellaneous operating system interfaces.

process
pygame

Game sub-process

A 2D game development module for Python.

Queue

Main, GUI thread,

Creates synchronised queues that facilitate

Robot thread, Serial

communication between threads.

thread, Game subprocess
random

Game sub-process

Used to generate pseudo-random numbers.

serial

Serial thread

Facilitates serial port communication.

sys

Game sub-process

Facilitates access to Python interpreter parameters and
functions.
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threading

Main, GUI thread,

High-level threading interface.

Robot thread, Serial
thread
time

Main, GUI thread,

Provides various time related functions.

Robot thread, Serial
thread, Game subprocess
wx

Main, GUI thread

Used for creating graphical user interfaces.

Table 3-3: Python modules used in the control computer software.

3.5.4.1. Threads	
  and	
  Sub-‐Processes	
  
The control computer sub-system consists of the main thread, three sub-threads and a
sub-process. All of the sub-threads are implemented as daemon threads. This means
they automatically terminate if MAIN terminates. Queues are used to communicate
between MAIN and all of the other threads and sub-processes. The Python “Queue”
module is used to facilitate queue communication between MAIN and the threads. The
“multiprocessing.Queue” module is used to facilitate communication between MAIN
and the game control sub-process. Both of these modules create First In First Out
(FIFO) queues, which are set to be three places long to avoid excessive system lags. For
this application, each queue is used for single direction, point-to-point communication.
A message put into the queue at one end can be read at the other end. All messages are
sent as Python lists with the following structure:
Message = [Message ID, Data]
An overview all of the queues used in this application is given in Figure 3-24 and a
description of the structure of each of the queue messages is given in Table 3-4.

83

Figure 3-24: An overview of the queues used to communicate between the threads and sub-processes.

Queue

Message

Name

ID

Gui_in

1

Data

Comment

state

The state of the MAIN state machine. Can have
values 1, 2, 3,4,5,6 or 7.

Gui_out

11

None

Sent when start button on GUI clicked.

12

None

Sent when stop button on GUI clicked.

13

None

Sent when exit button on GUI clicked. GUI thread
exiting.

Game_in

14

None

Sent when demonstrate button on GUI clicked.

21

None

Instruction to terminate game control sub-process.

22

Px, Py

Px: Position of end effector, x-axis.
Py: Position of end effector, y-axis.

Game_out

31

Dx, Dy

Dx: Distance from cursor to target, x-axis.
Dy: Distance from cursor to target, y-axis.

Robot_in

41

Dx, Dy

Dx: Distance from cursor to target, x-axis.
Dy: Distance from cursor to target, y-axis.
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42

None

Instruction to terminate therapy platform control
thread.

Robot_out

51

Fx, Fy, Px, Py, Px_t,

Fx: Force sensor x-axis reading.

Py_t, Cx, Cy

Fy: Force sensor y-axis reading.
Px: Position of end effector, x-axis.
Py: Position of end effector, y-axis.
Px_t: Timestamp for Px.
Py_t: Timestamp for Py.
Cx: Motor current, x-axis.
Cy: Motor current, y-axis.

uC_in

52

None

Therapy platform control thread is exiting.

61

None

Instruction to terminate microcontroller
communication thread.

uC_out

71

None

Emergency stop button pressed.

72

None

Force threshold exceeded

73

None

Microcontroller communication thread exiting.
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Fx, Fy

Fx: Force sensor x-axis reading.
Fy: Force sensor y-axis reading.

Table 3-4: Description of the structure of each of the queue messages.

3.5.4.2. MAIN	
  
MAIN is the top level of the control computer software. A flow diagram of MAIN is
shown in Figure 3-25. MAIN is implemented as a variation on a finite state machine.
There are seven possible states: WAIT, DEMONSTRATE, INITIALISE, RUNNING,
STOP, EXIT and EMERGENCY. These are discussed in turn in the following
paragraphs:

85

• WAIT
When MAIN is started, it is set to be in the WAIT state. In this state, the GUI thread
is started. The program waits for a command to be inputted by the user through the
GUI and then transitions to the appropriate state (DEMONSTRATE, INITIALISE or
STOP).
• DEMONSTRATE
This state is used for demonstrating the functionality of the game to the person using
the therapy platform without having to activate the therapy platform itself. If the state
machine is in the WAIT state and the ‘demonstrate game’ button on the GUI is
clicked then the state machine transitions to the DEMONSTRATE state. In this state
the Game Control sub-process is started in demonstrate mode. This means that a
mouse attached to the control computer can be used to move the cursor around the
screen, rather than the therapy platform end-effector, which is the case in the
RUNNING state. If the ‘stop’ button on the GUI is clicked, the state machine
transitions back to the WAIT state.
• INITIALISE
If the state machine is in the WAIT state and the ‘start’ button on the GUI is clicked,
the state machine transitions to the INITIALISE state. In this state the Game Control
sub-process and the Therapy Platform Control thread are started. The state machine
then transitions to the RUNNING state.
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Figure 3-25: Simplified flow diagram of MAIN
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• RUNNING
In the RUNNING state, the therapy platform is fully operational. A log file is created
and all the information received from the Gui_out, Robot_out and Game_out queues
is written to this log. If the ‘stop’ or ‘exit’ buttons on the GUI are clicked, if the
emergency stop button is pressed, if a force threshold is exceeded or if a system fault
occurs then the state machine transitions to the STOP state.
• STOP
In this state, the Game Control sub-process and the Therapy Platform Control thread
are both stopped. If the program transitions to the STOP state because the emergency
stop button is pressed, a force threshold is exceeded or a fault with the motor
controllers is detected then the program next transitions to the EMERGENCY state.
If the program transitions to the STOP state because the ‘stop’ button on the GUI is
clicked then the state machine next transitions to the WAIT state, ready to be
restarted. Finally, if the program transitions to the STOP state because the ‘exit’
button on the GUI is clicked then the program next transitions to the EXIT state.
• EMERGENCY
In this state, a message is printed to the control computer terminal indicating that a
fault or emergency situation has occurred. The program runs in a continuous loop
that can only be broken by quitting the program. This ensures that the therapy cannot
be restarted again instantly.
• EXIT
In this state, the GUI thread is terminated and MAIN exits, quitting the program.
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3.5.4.3. GUI	
  Control	
  Thread	
  
The GUI control thread generates a Graphical User Interface (GUI) that is displayed on
the screen of the control computer. A screenshot of the GUI is shown in Figure 3-26.
The GUI is created using wxPython [103]. After the GUI is created, an event
monitoring loop is started. This continuously searches for events, such as a button being
clicked, and then executes a method linked to that event. The GUI is implemented as a
separate thread so that this event monitoring loop could run in parallel with the other
parts of the control computer program. For this application, there are methods for the
‘start’, ‘demonstrate game’, ‘stop’ and ‘exit’ buttons. All of these methods send a
unique message via the Gui_out queue to MAIN, where they cause a change in the state
of the MAIN state machine.

Figure 3-26: A screen shot of the graphical user interface (GUI)

The GUI also displays the state of the MAIN state machine. To do this, a custom timer
event is created that executes an on_timer method once every 250ms. This method
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checks for messages sent from MAIN through the Gui_in queue and then changes the
GUI display in response.

3.5.4.4. Game	
  Control	
  Sub-‐Process	
  
The Game Control sub-process controls the 2D game that is displayed on the LCD
monitor mounted in front of the person using the therapy platform. The control
computer has a dual core processor. Therefore, implementing Game Control as a subprocess allows it to run on a separate core to MAIN and the three sub-threads. This
maximises the use of available system resources.
The pygame module is used to create the game. Pygame is a Python layer implemented
on top of the SDL multimedia library [104], which is in turn originally written in the C
programming language. A simple 2D game has been developed for the purpose of
testing the therapy platform. A screenshot of this game is shown in Figure 3-27. The
area of the screen represents the movement envelope of the therapy platforms arm
orthotic, the blue circle represents the current position of the arm orthotic and the red
and white circle represents the target position of the arm orthotic.

Figure 3-27: A screen shot of the game. This is displayed to the LCD monitor to the person using the
therapy platform. The blue circle represents the position of the therapy platform arm orthotic and the red
and white circle represents the movement target.

90

A flow diagram of the Game Control sub-process is shown in Figure 3-28. The game
operates very simply. When the arm orthotic is moved to the target position a new target
position is automatically generated.

Figure 3-28: Simplified flow diagram of Game Control Sub-Process
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The distance from this new target position to the current position of the arm orthotic is
then calculated. If it is greater than a set value then the new target is displayed on the
monitor. Otherwise a new target position is generated and the process is repeated. The
trajectory from the arm orthotic to the target is also constantly calculated and sent back
to MAIN through the Game_out queue. This information is necessary for providing
assistance during active-assist therapy and also for assessing how well a person has
completed a movement task during active therapy.

3.5.4.5. Therapy	
  Platform	
  Control	
  Thread	
  
The robot thread contains the robot control algorithms and handles communication with
the motor controllers. The motor controllers communicate with the control computer
through a CANopen bus and a USB-to-CAN interface. A manufacturer supplied
Dynamic Link Library (DLL) then provides a group of functions that can be called
using the Python ‘ctypes’ module. This allows the therapy platform control thread to
send commands and receive data from the motor controllers.
A flow diagram of the Robot thread is shown in Figure 3-29. Currently, it is only set up
to administer active therapy. However, an active-assist option can be implemented by
implementing a suitable new version of the Controller Method (described in Figure
3-30). When the Therapy Platform Control thread is started, it immediately starts the
Microcontroller Communication thread. The Microcontroller Communication thread
then continuously sends data from the force sensor, built into the arm orthotic, to the
Therapy Platform Control thread via the ‘uC_out’ queue. Further information on the
force sensor and arm orthotic is presented in Section 3.3.4. The motor controllers are
then initialised and the Therapy Platform Control thread continuously acquires data
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from them on the current position of the arm orthotic. This data is obtained by the motor
controllers from the Hall Effect sensors built into each of the systems motors. When the
therapy platform is used in active mode, data from the force sensors is used to
determine the direction in which the person using the robot wishes to move their arm.

Figure 3-29: A simplified flow diagram of the therapy platform control thread. A flow diagram of the
CONTROLLER METHOD is shown in Figure 3-30.

A command is then sent to each of the motor controllers instructing them to send a
current to the motors such that this current compensates for any friction inherent in the
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system when the person moves their arm. If the therapy platform is to be used in activeassist mode then additional current is sent to each motor such that a force is applied to
the person’s arm that helps them to complete the set task. This additional current would
be determined from data on the trajectory from the current position of the arm orthotic
to the target. This data is provided by the Game Control sub-process, via MAIN.

Figure 3-30: A simplified flow diagram of the CONTROLLER METHOD for administering active
therapy.

3.5.4.6. Microcontroller	
  Communication	
  Thread	
  
The Microcontroller Communication thread handles serial communication between with
the control computer and the microcontroller, as per the communication protocol
discussed in Section 3.5.2. It is a sub-thread of the Therapy Platform Control thread.
Handling serial communication in a separate thread allows communication with the
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microcontroller to take place in parallel with the other activities of the therapy platform
control thread. This results in faster communication between the control computer and
the microcontroller. A flow diagram of the microcontroller communication thread is
shown in Figure 3-31.

Figure 3-31: Simplified flow diagram of the Microcontroller Communication Thread
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3.6. Bill	
  of	
  Materials	
  

A bill of the materials used in the construction of the therapy platform is given in
Appendix C. It includes information on what sub-assembly each component is part of,
the part number, the quantity used, a brief description and manufacturing information.
All screws, nuts and washers are numbered as being part of sub-assembly 004.
Electrical components are included as sub-assembly 005. Manufacturing drawings for
custom designed parts are provided in Appendix E. Also, from the bill of materials, the
approximate total cost of purchasing all necessary components for constructing the
therapy platform is €6,646.50. However, a reduction in this figure due to economies of
scale could be expected if the therapy platform was constructed in batch sizes larger
than one.
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Chapter 4

Discussion

4.1. Validity	
  of	
  Therapy	
  Platform	
  Design	
  Approach	
  

As no clinical trials were conducted, it is necessary to validate the therapy platform
described in Chapter 3 through similarity of design. Similarity of design involves
comparing the overall design of the therapy platform with the design of devices that
have been previously used in clinical trials with a view to determining the likely
effectiveness of this therapy platform in the administration of upper limb rehabilitation
therapy.
In Section 2.4.1.3, two complex robotic devices are mentioned, MIT Manus and
Gentle/s. The greatest similarity is between the described therapy platform and MIT
Manus, which is also a planar robot designed to administer rehabilitation exercises to
the upper limbs of post-stroke persons. While the MIT Manus end-effector moves
according to a polar co-ordinate system as opposed to a Cartesian coordinate system and
MIT Manus allows for a small amount of passive movement in the Z-axis, the available
workspace and general system layout of the described therapy platform and MIT Manus
are quite similar. The simple game played by users of the therapy platform, discussed in
Section 3.5.4.4, also resembles one of the games commonly used with MIT Manus.
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However, while the described therapy platform physically resembles MIT Manus, if
administering active-assist therapy, the therapy platform would have to operate in a
manner much more similar to Gentle/s, i.e. using the admittance control approach
described in Section 2.5.2.2 and the force sensor built into the arm orthotic. This is due
to the friction and inertia inherent in the design of the therapy platform, which is not
present in MIT Manus due of its use of easily back-drivable, low backlash motors.
These relatively high levels of friction also necessitate the use of the force sensor when
the therapy platform is being used in active mode, such that the direction of desired
movement can be determined using the force sensor and then the polarity of a friction
compensation current to the motors set such that it facilitates movement in the desired
direction.
The validity of the design approach to the therapy platform is thus based on its
similarity to both MIT Manus and Gentle/s. In Section 2.5.4, a number of clinical trials
involving MIT Manus were discussed, namely Aisen et al. [18], Volpe et al. [19], Krebs
et al. [32], Posteraro et al. [36], Fasoli et al. [29] and Lo et al. [37]. These trials all
demonstrated to beneficial effects of a course of rehabilitation therapy with MIT Manus.
A clinical trial using Gentle/s was also conducted by Coote et al. [33] that too showed a
positive treatment effect from a course of rehabilitation therapy using Gentle/s. Other
clinical trials discussed in Section 2.5.4 using the MIME admittance control based
system have also shown positive outcomes (Lum et al. [21][28]). Based on the results of
these trials, it is reasonable consider that the general approach to the design of the
described therapy platform is suitable for administering effective rehabilitation therapy
to the upper limbs of individuals post-stroke, the main point of difference being that the
device described in this document is intended to be a lower cost device.
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4.2. Discussion	
  of	
  Research	
  Question	
  

In Section 1.2, the following research question is stated:
Is it possible to develop a low cost technological device for assisting in post-stroke
rehabilitation therapy for the upper limbs in a local clinic or domestic setting?
This research question can be broken down into two sub-questions. The first is whether
the described therapy platform is a low cost device. The second is whether the described
therapy platform is suitable for use in a local clinic or domestic setting. These questions
are answered in turn in the following sections.

4.2.1. Is	
  the	
  therapy	
  platform	
  a	
  low	
  cost	
  device?	
  
For a therapy device intended for use in a local clinic or domestic setting, it is desirable
that the cost is as low as possible. In the Bill of Materials (Section 3.6), the total cost of
purchasing all of the necessary components for constructing the therapy platform
described in this document is given as €6,646.50. Some components, particularly
passive electrical components, were available free of charge from DIT and hence are not
included in this figure. Therefore, a reasonable total cost, including the cost of
purchasing these components, would probably be about €7,000.
Whether or not something is low cost is always relative. Therefore, does €7,000
represent a low cost platform for administering rehabilitation therapy? In an economic
analysis of robot-assisted therapy conducted by Wagner et al. [105], it is stated that the
purchase price of a MIT Manus style robotic device is €175,169 ($230,750). MIT
Manus is a complex robotic device for administering active-assist therapy and was
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discussed in Section 2.4.1.3 of this document. Even though the €7,000 figure for
purchasing components for the therapy platform described in this document excludes
any assembly costs, company running costs or profit margins, the cost of the described
therapy compares favourably with the cost of the MIT Manus style device. This is partly
attributable to differences in device geometry; MIT Manus has a SCARA geometry
whereas the device described in this document uses a much simpler Cartesian approach.
Another factor is the differences between the motors used to actuate the two devices.
MIT Manus uses expensive custom low backlash motors whereas the device described
in this document uses cheaper Commercial Off-The-Shelf (COTS) motors. The
approach taken with MIT Manus is aimed at optimal device performance whereas the
approach taken with the therapy platform described in this document is aimed at
minimising device costs and using innovations in software to compensate for any
deficiencies in performance.

4.2.2. Is	
  the	
  therapy	
  platform	
  suitable	
  for	
  use	
  in	
  a	
  local	
  clinic	
  or	
  domestic	
  setting?	
  
Some of the issues that are important for rehabilitation devices intended for use in a
local clinic or domestic setting were previously mentioned in Section 2.6. These issues
are again listed below and discussed in relation to how they apply to the developed
therapy platform.

4.2.2.1. Patient	
  Safety	
  
A strong consideration throughout the development of the therapy platform has been the
safety of the person using it. One of the main risk factors identified at the beginning of
the design phase is from excessive force being administered to a person’s arm by the
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therapy platform. This could be from a single jerking motion or from instability in the
control system that causes the end-effector to oscillate in an uncontrolled manner. As
such, the default action of the robots operating software in the case of any detected
emergency or undesirable system behaviour is to switch off all power to the therapy
platforms motor controllers. However, before this therapy platform or any future
prototypes are considered for use with post-stroke patients, a comprehensive risk
assessment in accordance with ISO14971:2007 should be conducted. This will fully
quantify any risks to patient safety from the device. Design features and operation
procedures can then be adjusted to minimise any identified risks in an iterative manner.

4.2.2.2. Ease	
  of	
  Device	
  Setup	
  
For a device such as this to be suitable for use in a local clinic or domestic setting it is
imperative that the device is easy to set up either by the person undergoing
rehabilitation themselves or by a helper. The person using the device cannot be assumed
to be technically competent or highly trained. To achieve this, the user interface for
controlling the device was kept as simple as possible. Also, for the prototype described
in this document, a person’s arm is secured to the arm orthotic with Velcro straps. It is
desirable that for future iterations of the device that when a person rests their arm on the
arm orthotic it is automatically gripped by it and then automatically released in an
emergency situation or when the therapy session has been completed. This would make
the device much easier for a person on their own to use.
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4.2.2.3. Remote	
  Progress	
  Assessment	
  and	
  Interaction	
  between	
  Therapists	
  and	
  Patients	
  
It is necessary that any rehabilitation device for use in a local clinic or domestic setting
allows the therapist to remotely monitor the progress of the patient. To this end further
research such as that described in Section 2.2.5 (Robot Based Assessment) would be
useful. As manually applied methods, such as the Fugl-Meyer assessment, are the
accepted norm for quantifying a post-stroke person’s movement ability, this research
aims to predict a person’s score on these manually applied scales using kinematic data
gathered during a course of robot mediated rehabilitation therapy. This has the potential
to allow therapists to monitor the progress of their patients using the therapy platform in
a remote location in a way they are already familiar with.

4.3. Conclusion	
  

The three high level objectives presented in Section 1.2.1 have all been successfully
completed. As per the first objective, a comprehensive literature review was undertaken
covering stroke, post-stroke recovery, patient assessment, rehabilitation therapy,
technological approaches to rehabilitation and an in-depth look at robot administered
therapy. This literature review is presented in Chapter 2 and it main outcome is that
intensive movement therapies, of the type delivered by robotic rehabilitation devices,
are capable of producing significant and sustained gains in motor function in people
with upper limb impairment post-stroke. However, while these gains are not superior to
those obtained from an equally intensive approach, a robotic approach has the potential
to be more motivational for people undergoing therapy. More motivated individuals are
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likely to undertake more therapy, which is linked to improved motor function outcomes.
These features of robot therapy may make it particularly suitable for use in a local clinic
or domestic setting where the person undergoing therapy is relatively unsupervised or a
suitably qualified therapist is unavailable. Also, as discussed in Section 2.6, for a device
such as this to be suitable for use in a local clinic or domestic setting it is essential that
its construction is as low cost as possible.
Following on from this, in Chapter 3 the design of a first prototype therapy platform for
assisting in the rehabilitation of the shoulder/elbow region of the upper limbs of persons
post-stroke in a local clinic or domestic setting is discussed in accordance with the
second objective presented in Section 1.2.1. In this chapter, some functional
requirements for the therapy platform are outlined along with a description of the design
of the therapy platforms mechanical, electronic and software systems. A bill of all of the
materials used in the construction of the therapy platform is also presented and from this
it was determined that the cost of all of the components used in the construction of the
therapy platform came to €6,646.
Finally, the therapy platform is discussed in Chapter 4 in accordance with the third
objective presented in Section 1.2.1. Here, the general approach to the design of the
therapy platform is validated through similarity of design, by comparing it with other
devices described in the literature review. The cost of the described therapy platform is
also found to compare favourably with the cost of other devices for administering
active-assist therapy. Furthermore, a direction for developing a future iteration of the
prototype device is also presented revolving around completing a comprehensive risk
assessment in accordance with ISO14971:2007 and then making design improvements
to minimise risk to the user in accordance with the outcome of this assessment. The
desirability of being able to remotely assess the progress of individuals undergoing
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therapy in a local clinic or domestic setting is also discussed in Chapter 4. The therapy
platform described in this document, and many other technological approaches to poststroke rehabilitation, are also capable of gathering large amounts of kinematic data as a
person uses the device. However, this data is not in a form that can be readily
understood or interpreted by physiotherapy professionals. Although two relevant
clinical trials in this area were discussed in Section 2.2.5, there are no established
methods for converting this data into such a form. As such, additional research on
extrapolating standard patient assessment scale results from the kinematic data gathered
during technology assisted rehabilitation sessions would be beneficial. This is
particularly important for devices intended for use in a local clinic or domestic setting
as it would allow therapists to monitor the progress of their patients as they undertake
therapy in a remote environment.
Another area with huge potential for future work is the screen that the person using the
device looks at as they undertake therapy. On the therapy platform described in this
document, the screen displays a simple game for both instructing and motivating
persons using the device. There are a large number of commercial games available for
Windows and Android operating system platforms that, with an intermediary software
layer, could be used to provide and even more motivational rehabilitation environment.
Migrating to an Android platform could also facilitate the development of Apps that
allow persons undergoing rehabilitation to interact or play games against other people
undergoing rehabilitation or family members. This has the potential to motivate more
people to undergo more intensive therapy for longer periods of time, which will directly
lead to improved outcomes. This software should ideally not be device specific so that
people using a range of different devices (for wrist, finger or lower limb rehabilitation)
can all potentially interact through the same software environment.
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Appendix A:

List of Publications

“Interactive Robotics for Medical Rehabilitation”
Conference Paper, June 2009. MATRIB conference. Vela Luka, Croatia.
The conference paper was subsequently published in the conference proceedings.

“Development of a robotic platform for upper limb rehabilitation”
Conference Paper, 2012. 15th Annual Sir Bernard Crossland Symposium, held in Dublin
City University (DCU).
The conference paper was subsequently published in the conference proceedings and on
the DIT Arrow database of publications.

The main author also has a number of publications associated with his involvement in
the DIT Telescobe project. The Telescobe project involved developing an experiment to
test a novel, carbon-fibre, telescopic boom system suitable for deploying sensors (such
as electromagnetic field probes and Langmuir probes) from sounding rockets for use in
upper atmospheric research. The Telescobe experiment was launched on the REXUS 9
sounding rocket in February 2011 and again on the REXUS 11 sounding rocket in
November 2012, from Esrange space centre in Northern Sweden.

The author’s

responsibilities included being team leader, system engineering and electronic system
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design. The project was undertaken as part of the REXUS/BEXUS program for
University students organised by the German Aerospace Centre (DLR), the Swedish
Space Corporation (SSC), the Swedish National Space Board (SNSB) and the European
Space Agency (ESA). More information on this project can be found at the Telescobe
team website: spaceresearch.dit.ie. The publications associated with the Telescobe
project are as follows:

“A novel telescopic boom deployment system for use in upper atmosphere research”
Conference Paper, June 2010. MATRIB conference. Vela Luka, Croatia.
The conference paper was subsequently published in the conference proceedings.

“Developing a carbon fibre, telescopic boom for the Telescobe REXUS project”
Conference Paper, October 2010. International Manufacturing Conference 27, Ireland.
The conference paper was subsequently published in the conference proceedings and on
the DIT Arrow database of publications.

“Deployment and characterisation of a telescopic boom for sounding rockets”
Conference Paper, May 2011. 20th ESA Symposium on European Rocket and Balloon
Programmes and Related Research. Hyères, France.
The conference paper was subsequently published in the conference proceedings and on
the DIT Arrow database of publications.
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Appendix B:

Patient Assessment Scales

B.1.

Fugl Meyer Assessment – Motor Functioning Domain

B.2.

Functional Independence Measure

120

B.1.	
   Fugl-‐Meyer	
  Assessment	
  –Motor	
  Functioning	
  Domain	
  

When the motor functioning domain (both upper and lower extremity) is administered
on its own, it takes about twenty minutes to complete. The person being assessed is
given verbal instructions to make specific movements and is then scored based on the
assessor’s direct observation of their performance. The subject is asked to perform the
movement with the non-affected limb first and subsequently to perform the same
movement with the affected limb. On the affected side, each movement is repeated three
times and only the best performance is scored. The person being assessed is not assisted
in any way, except verbally, to complete the task [106]. Each individual task that the
subject performs is scored on the ability of the subject to complete the task using a
three-point scale outlined in Table B-1.
Score

Meaning

0

Subject cannot perform the task

1

Subject can partially complete the task

2

Subject can fully complete the task
Table B-1: Fugl-Meyer assessment scoring details.

Total final results for the motor functioning domain of the Fugl-Meyer assessment will
range from 0 to 100 points, with a score of 0 indicating that the subject is hemiplegic
and a score of 100 indicating that the subject has normal motor performance. This total
of 100 points can be further divided into 66 points allocated for measuring the
functioning of the upper body and 34 points allocated for the functioning of the lower
body [106]. An example of assessment sheets that could be used while administering
the motor functioning domain of the Fugl-Meyer assessment is given below. These
assessment sheets were obtained from Goteborgs Universitet [107].
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B.2.	
   Functional	
  Independence	
  Measure	
  

Each item on the functional independence measure is scored on a seven-point scale
where the score indicates the amount of assistance required to perform each task.
1 = total assistance in all areas
7 = total independence in all areas
A final summed score is then created, ranging from 18 - 126, where 18 represents the
subject being completely dependent and 126 indicates that the subject is completely
independent [108].
An assessment sheet that could be used when performing a Functional Independence
Measure assessment is given below. This assessment sheet was obtained from [109].
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Appendix C:

Bill of Materials

The table below is a bill of materials for the therapy platform. The unit cost does not
include VAT.
Sub-

Part

Assembly

#

001

001-

Qty.

Description

Manuf.

Manuf. Part No.

Unit Cost

1

Cross Member 1

Custom

Manufacturing drawing

€100.00*

001
001-

provided in Appendix E.
1

Cross Member 2

Custom

002
001-

Manufacturing drawing

€100.00*

provided in Appendix E.
2

003

635x50x50mm

Misumi

HFS8-5050-635

€19.05

Misumi

HFS8-5050-120

€9.20

Nu-Tech

A300/001

€13.52

Misumi

HNTT8-8

N/A

Custom

Manufacturing drawing

€50.00*

Extruded
Aluminium Section

001-

4

004
001-

Aluminium Section
4

005
001-

12

2

Long Shaft Support
Bracket

2

008
001-

M8 Aluminium
Section Mounts

007
001-

Adjustable
Mounting

006
001-

120mm Extruded

Short Shaft Support

provided in Appendix E.
Custom

Bracket
1

Long Shaft

Manufacturing drawing

€75.00*

provided in Appendix E.
Misumi

009

127

SFJ-10-663

€18.89

001-

1

Motor Bracket 1

Custom

010
001-

€75.00*

provided in Appendix E.
1

Motor Bracket 2

Custom

011
001-

Manufacturing drawing

Manufacturing drawing

€50.00*

provided in Appendix E.
2

Guide Rail

Hepco

N/A

N/A

1

EC Motor

Maxon

323772

€176.34

1

Large Pulley

RS

27T5/60-0

€25.31

5

Small Pulley

RS

21T5/19-2

€12.65

6

Bearing

Misumi

C6000ZZ

€2.70

2

Short Shaft

Misumi

SFJ-10-75

€3.12

2

Long Belt

Contitech

950-5M-9

N/A

1

Short Belt

Contitech

475-5M-9

N/A

1

Moving Beam

Custom

Manufacturing drawing

€100.00*

012
001013
001014
001015
001016
001017
001018
001019
002

002001
002-

provided in Appendix E.
1

002
002-

004

Custom

Bracket 1
1

003
002-

Guide Wheel

Guide Wheel

Belt Adjustment

€50.00*

provided in Appendix E.
Custom

Bracket 2
1

Manufacturing drawing

Manufacturing drawing

€75.00*

provided in Appendix E.
Custom

Bracket

Manufacturing drawing
provided in Appendix E.
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€100.00*

002-

1

Motor Bracket 3

Custom

005
002-

1

Arm Orthotic

Custom

Interface Bracket
1

Belt Clamp 1

Custom

2

Manufacturing drawing

Belt Clamp 2

Custom

Manufacturing drawing

8

Guide Wheel

N/A

N/A

N/A

N/A

Inserts
4

Guide Wheel

Hepco

1

Short Shaft Support

See sub-assembly 001

008
001-

Bracket
1

Motor Bracket 2

See sub-assembly 001

2

Guide Rail

See sub-assembly 001

1

EC Motor

See sub-assembly 001

1

Large Pulley

See sub-assembly 001

3

Small Pulley

See sub-assembly 001

4

Bearing

See sub-assembly 001

1

Short Shaft

See sub-assembly 001

011
001012
001013
001014
001015
001016
001-

€25.00*

Hepco

010
001-

€25.00*

provided in Appendix E.

009
002-

€50.00*

provided in Appendix E.

008
002-

Manufacturing drawing
provided in Appendix E.

007
002-

€75.00*

provided in Appendix E.

006
002-

Manufacturing drawing

017
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001-

1

Long Belt

See sub-assembly 001

1

Short Belt

See sub-assembly 001

1

Main bearing

Misumi

NKXZ35

€65.70

1

Force sensor cover

Custom

Manufacturing

€90.00

018
001019
003

003001
003002

drawing
provided in
Appendix E.

003-

1

Main bearing shaft

Misumi

003

PSPJQ50-25-

€16.30

F32-P35-T6Q40

003-

1

Lower arm rest

Custom

005

Manufacturing

€105.00

drawing
provided in
Appendix E.

003-

8

Roller bearing

Misumi

BCHA11

€8.30

1

Upper arm rest

Custom

Manufacturing

€92.00

006
003007

drawing
provided in
Appendix E.

003-

1

Thread converter

Custom

009

Manufacturing

€35.00

drawing
provided in
Appendix E.

003010

1

Upper Arm Rest

Misumi

Bushing Shaft

FCLSAW-D6L14-MC4
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€9.20

003-

1

011
003-

Upper Arm Rest

Misumi

SHFZ6-12

€4.40

Misumi

DXFL-D10-V8-

€5.30

Bushing
1

Urethane Sleeve

012
003-

T2-L6-C3
1

Clamping Plate

Misumi

013

KBLAF1.5-

€10.70

A60-B50-X5Y5-F50-G40N3-NA3

003-

1

Top Plate

Misumi

014

KBLAY2.0-

€14.10

A160-B60-X5Y5-F80-G50V70-S5-W50N3-NA3

003-

1

015

Force Sensor

Custom

Mounting Plate

Manufacturing

€52.00

drawing
provided in
Appendix E.

003-

2

Hand Slider Rail

Misumi

016
003-

SSFQ6-150-

€10.74

B20
1

Hand Slider

Custom

017

Manufacturing

€53.00

drawing
provided in
Appendix E.

003-

1

Biaxial Load Arm

Futek

018
002-

MBA400
4

009
002-

FSH01071 -

Guide Wheel

See sub-assembly 002

Inserts
4

Guide Wheel

See sub-assembly 002

010

131

€1862.00

004

004-

2

001
004-

2

8

6

M3 x 5 Socket Set

Misumi

MSSFS3-5

€0.25

M3 x 6 SHC Low

Misumi

CBSST3-6

€0.57

M3 x 10 SHC Extra

Misumi

CBSTS3-10

€0.31

Misumi

CBSST3-12

€0.57

Low Head
8

005
004-

€0.25

Head

004
004-

MSSFS3-4

Screw

003
004-

Misumi

Screw

002
004-

M3 x 4 Socket Set

M3 x 12 SHC Low
Head

4

M3x8 SHC

Misumi

CBE-3-8

€0.69

4

M3 Washer

Misumi

PWF-3

€0.13

6

M4x12 SHC

Misumi

CBE-4-12

€0.79

6

M4 Washer

Misumi

PWF-4

€0.13

2

M6x12 SHC

Misumi

CBE-6-12

€0.74

2

M6 x 12

Misumi

SFB-6-12

€0.58

006
004007
004008
004009
004010
004011
004-

Countersink
22

M6x15 SHC

Misumi

CBE-6-15

€0.74

2

M6x15 Countersink

Misumi

SFB-6-15

€0.58

26

M6x25 SHC

Misumi

CBE-6-25

€0.79

012
004013
004014
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004-

4

M6x40mm SHC

Misumi

CBE-6-40

€0.99

4

M6 Hex Nut

Misumi

LBNR-6

€0.78

62

M6 Washer

Misumi

PWF-6

€0.16

8

M8x25 SHC

Misumi

CBE-8-25

€0.99

4

M8x40 Full Thread

Misumi

FABBN-8-40

€9.08

015
004016
004017
004018
004019
004-

Screw
8

M8 Washer

Misumi

PWF-8

€0.39

4

#8-32 x 3/4" Screw

RS

274-5222

€0.05

1

Laptop Computer

HP Compaq

Business Noteb

€1189.00

020
004021
005

005001
005-

ook 6730b
1

LCD Monitor, 22"

NEC

60002791

€222.25

2

Motor Controller

Maxon

EPOS24/5

€433.00

1

USB-to-CAN

Ixxat

1.01.0087.

€573.28

002
005003
005004

compact with SUB-

10200

D9 plug and
galvanic decoupling
005-

1

Arduino UNO

Arduino

UNO

€21.72

1

Power Supply, 0-

Elektro-Automatik

EA-PS 832-10R

€418.96

Analog Devices

AD627BNZ

€9.54

005
005006
005007

32V, 10A, 320W
2

Instrumentation
Amplifier
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005-

1

Optocoupler

Sharp

009
005-

1

N-Channel Mosfet,

Vishay

3.5A
1

011
005-

€0.18

F

010
005-

PC123X1YFZ0

Emergency Stop

IRFIBC40GPB

€3.04

F
Telemecanique

XALK194

€32.50

Button
1

SPST Switch

N/A

N/A

N/A

2

120Ω, 0.25W

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

012
005013
005-

Resistor
5

014
005-

Resistor
1

015
005-

10KΩ, 0.25W
Resistor

1

016
005-

250Ω, 0.25W

1KΩ, 0.25W
Resistor

2

0.1µF Capacitor

N/A

N/A

N/A

4

2KΩ, 0.25W

N/A

N/A

N/A

N/A

N/A

N/A

017
005018
005-

Resistor
2

019
005-

200Ω, 0.25W
Resistor

2

1µF Capacitor

N/A

N/A

N/A

1

LED Green

N/A

N/A

N/A

1

LED Blue

N/A

N/A

N/A

020
005021
005022
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005-

2

LED Red

N/A

N/A

N/A

2

Cables for biaxial

Futek

FSH01790 -

N/A

023
005025
005-

load arm
1

026

Breadboard for

ZCC940
N/A

N/A

€8.19

N/A

N/A

€20.00

N/A

N/A

N/A

N/A

N/A

N/A

TE Connectivity

3-1634581-2

€2.67

TE Connectivity

3-1634223-2

€2.69

prototyping
electronics

005-

1

027
005-

for electronics
1

028
005-

Plastic enclosure

USB type A to USB
type B cable

1

029

30mm x 50mm
electrical strip
board

005-

1

030

male, 15 way, right
angle, D-Sub
connector

005-

1

031
005-

female, 15 way DSub connector

1

LED Cable Harness

N/A

N/A

N/A

1

2m long, two-core,

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

032
005033
005-

sheathed cable
1

034
005-

(Red)
1

035
005036

Power supply cable

Power supply cable
(Black)

1

Female power
supply socket (Red)
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005-

1

037

Female power

N/A

N/A

N/A

N/A

N/A

N/A

supply socket
(Black)

005038

2

Cable to connect
EC motor to its
motor controller.

* Estimated figure
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Appendix D:

Data Sheets

D.1.

Maxon EC-90 Flat Motor

D.2.

Maxon EPOS 24/5 Digital Position Controller

D.3.

IXXAT USB-to-CAN Compact with SUB-D9 Plug and Galvanic Isolation

D.4.

FUTEK 50lb Biaxial Load Arm

D.5.

Analog Devices AD627BNZ Instrumentation Amplifier

D.6.

Arduino UNO (with ATMEL ATmega328P-P Microcontroller)
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D.1.	
   Maxon	
  EC-‐90	
  Flat	
  Motor	
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D.2.	
   Maxon	
  EPOS	
  24/5	
  Digital	
  Position	
  Controller	
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D.3.	
   IXXAT	
  USB-‐to-‐CAN	
  Compact	
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D.4.	
   FUTEK	
  50lb	
  Biaxial	
  Load	
  Arm	
  

143

D.5.	
   Analog	
  Devices	
  AD627BNZ	
  Instrumentation	
  Amplifier	
  

144

D.6.	
   Arduino	
  UNO	
  (with	
  ATMEL	
  ATmega328P	
  Microcontroller)	
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Appendix E:

Manufacturing Drawings of
Custom Parts
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E.1.	
   Part	
  Number	
  001-‐001	
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E.2.	
   Part	
  Number	
  001-‐002	
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E.3.	
   Part	
  Number	
  001-‐007	
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E.4.	
   Part	
  Number	
  001-‐008	
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E.5.	
   Part	
  Number	
  001-‐010	
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E.6.	
   Part	
  Number	
  001-‐011	
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E.7.	
   Part	
  Number	
  002-‐001	
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E.8.	
   Part	
  Number	
  002-‐002	
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E.9.	
   Part	
  Number	
  002-‐003	
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E.10.	
  Part	
  Number	
  002-‐004	
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E.11.	
  Part	
  Number	
  002-‐005	
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E.12.	
  Part	
  Number	
  002-‐006	
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E.13.	
  Part	
  Number	
  002-‐007	
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E.14.	
  Part	
  Number	
  002-‐008	
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E.15.	
  Part	
  Number	
  003-‐002	
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E.16.	
  Part	
  Number	
  003-‐005	
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E.17.	
  Part	
  Number	
  003-‐007	
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E.18.	
  Part	
  Number	
  003-‐009	
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E.19.	
  Part	
  Number	
  003-‐015	
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E.20.	
  Part	
  Number	
  003-‐017	
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